Proportional relationships 7th grade worksheet pdf

Encouraging Progress since 2012

2012.12.11 05:43 Encouraging Progress since 2012

The Valhalla Challenge is a recovery game that helps people replace pornography use with self-care. We use proven recovery tools, including the wisdom traditions, neuroscience, and gamification. By focusing on the solution rather than the problem, we power ourselves up, change behaviors, and support our community.
[link]


2023.03.25 01:16 XhetherC Silly coder man gets silly results

Demographics
Intended Major(s): Computer Science
Academics
Standardized Testing
List the highest scores earned and all scores that were reported.
Extracurriculars/Activities
List all extracurricular involvements, including leadership roles, time commitments, major achievements, etc. [sorry for vague-ness lol]
  1. #1 FRC programming subteam lead (we qualified for world's last year) - a lot of time, member all 4 years
  2. #2 Varsity Tennis Captain (we won our league last year for the 1st time in 8 years and I also typically start as #1 singles) - a lot of time, active all 4 years
  3. #3 Developed an app over the summer (not published) - a lot of time
  4. #4 Varsity Mathletes - not a lot of time, active all 4 years
  5. #5 School Computer Science and Multimedia pathway representative - not a lot of time , 11th and 12th
  6. #6 Member of school cyber patriot team (cybersecurity competition) - decent chunk of time, active all 4 years
  7. #7 Tennis representative for athletic leadership club - not a lot of time, 11th and 12th
  8. #8 Student representative for local activist organization against police violence in schools - not a lot of time
  9. #9 FIDM fashion club (discontinued but I was pretty active during 9th grade) - N/A
Awards/Honors
List all awards and honors submitted on your application.
  1. #1 Questbridge Finalist
  2. #2 FRC Dean's List Semi-Finalist
  3. #3 Adobe Certified Professional in Visual Design (illustrator and photoshop)
  4. #4 Regional Chairmans Award Winner (FRC, this is a team award, championship qualifying)
  5. #5 CollegeBoard African American Recognition Award
Letters of Recommendation
(Briefly describe relationships with your recommenders and estimated rating.)
CS Teacher 10/10 - I love this guy and I think he loves me too so that explains the rating. He's taught me 9th-11th grade and he also is active in my school's robotics team so we bonded well
Calc AB Teacher 10/10 - honestly he's just a really nice guy and we get along really well, even when I wasn't in his class cause of ECs he was always very lenient with me and I really liked his classes too
Interviews
(Briefly reflect on interview experiences, if applicable.)
MIT 9/10 - Honestly pretty nice, was over zoom cause he had covid but he seemed a lot like me and we joked a lot and it was pretty chill
Cornell (alumni meeting) 9/10 - really cool guy, I had to drive over an hour away for this but it was worth it and he bought me a lemonade as well as my family's (including gf) food.
Yale 7/10 - a little silly and I was pretty confused about the direction of the interview most of the time; I was a bit late but the interviewer was really chill and she bought me Starbucks + she was really excited when I was telling her about how I like one piece and program robots
Princeton 8/10 - Pretty chill, I was extra nervous for some reason and it was hard to hear my interviewer sometimes but it worked out and he seemed pretty happy to be doing the interview and he also told me some pretty wholesome stuff about his experiences at Princeton so that was nice
Essays
(Briefly reflect on the quality of your writing, time spent, and topic of main personal statement.)
8.5/10 - Idk how to accurately score it and I am second-guessing it a bit cause of some of my recent decisions (not gonna go back and review it tho lol) but it was about not being able to measure up to who I want to be and always coming a bit short but also being able to appreciate life and develop without relying on metrics like scores and awards (validation). It was a more fine-tuned version of my questbridge essay and that did work (or at least to the QB peeps) so I have to assume this was a bit better.

Decisions ( All RD)
Acceptances :
Waitlists:
Rejections:
Waiting:
Additional Information:
(anything of relevance)
I only reported AP scores to UC's and I think taking the dual enrollment classes were good for me cause they reminded me that I wanna study CS and it showed me what it will be like in college to some extent but I also totally overwhelmed myself, had to go pass/fail (I passed both) and probably wrote a few sloppy essays but it is what it is. Not too sure why I applied to so many places and I think my AP scores are a bit suspicious but I'm really just not a good test taker (as you can see) and not the greatest at studying and I don't suck at CS (not amazing though maybe not even good for this sub lol) I've been coding since 7th grade primarily in robotics but I lazily studied for like a few days and it was my birthday and I was kinda out of it at that point but anyways I'll update this next week and I'm not too sure why I got a likely letter but I'm super grateful (and I honestly love Cornell <3) and it lets me take my mind off of this college admissions hell LOL. I do think being a QB finalist made me stand out a bit for my common app especially since my identity was a big part of my narrative. Also, don't grill me too hard I perform pretty well at MY high school, nationally I'm prob a bit average but that's ok too. I also explained my depression in some extra section as well as my geometry grade, which I assume wasn't too awful cause I got A+'s in calculus afterward.
submitted by XhetherC to collegeresults [link] [comments]


2023.03.24 19:42 i_know_nothing123 Astrology observations I made pt 35

DISCLAIMER- Placements will not play out the same way for everyone and having challenging placements + aspects does not mean that you are a bad person or that you will have a bad life. Take what resonates and leave what doesn’t
-Neptune in the 12th house conjunct ascendant can indicate that your mom didn’t know she was pregnant with you for a while, or that her baby bump did not show for a long time during the pregnancy so nobody knew
-people with Venus in the 7th house usually aren’t into superficial relationships, especially if Venus is in an earth sign. They date long-term, I would even say they date to marry
-mars-Uranus aspects can indicate being accident and injury prone, especially if they are conjunct
-Neptune in the 4th house can indicate growing up sheltered and not having an accurate picture of what “the real world” is like. Think rapunzel and mother gothel
-Uranus in the 3rd house can indicate being socially awkward and not really having a firm grasp on social cues
-Virgo and Pisces venuses, your partners aren’t science projects, it’s not your job to try and fix anybody
-Leo placements and people with the Sun in prominent houses get attention regardless of if they actually seek it or not. Whether they are receptive to the attention or not depends on their other placements (ex- Pisces placements usually hate it and avoid it)
-if you are a cancer moon, your mom probably saw you as an extension of herself, whether your relationship with her was actually good or not
-Libra ascendants tend to have amazing body proportions, hourglass shape or not
-I feel like notorious or serial thieves would have heavy Gemini placements
Edit- this is pt 34, my finger slipped and put 5 instead 🙃
submitted by i_know_nothing123 to astrologymemes [link] [comments]


2023.03.24 16:52 SituationLive4406 $LSDI The first psychedelics manufacturing company to be listed on NASDAQ! Low float, building momentum, Recent IPO, Oversold, Looks Ready to Run

$LSDI The first psychedelics manufacturing company to be listed on NASDAQ! Low float, building momentum, Recent IPO, Oversold, Looks Ready to Run
Hello everyone,
Great Partnership News with High Times Out Yesterday!
Lucy Scientific Discovery Announces Partnership with High Times® to Develop and Distribute a New Line of Psychoactive Products
‘Mindful by Lucy’

https://preview.redd.it/gt8lt6k2lppa1.jpg?width=230&format=pjpg&auto=webp&s=ccb2e562b5774e49657e46889063d2b83c65aca1
New Line of Psychoactive Products
VANCOUVER, British Columbia, March 23, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. (“Lucy” or “The Company”) [NASDAQ:LSDI], a leading NASDAQ-listed psychedelic drug manufacturer, announced today the launch of a new line of unscheduled psychoactive compounds that will be available for sale throughout the United States, and where permitted throughout the rest of the world.
The first line in the new family of brands contains Amanita Muscaria mushrooms, a psychoactive adaptogen. The product leverages the compounds of these mushrooms, and a proprietary blend of other natural functional ingredients, to create a transformative experience for consumers worldwide. This product line is named ‘Mindful by Lucy’.
Lucy Scientific will produce Mindful with High Times, through a strategic partnership with Hightimes Holding Corp., the parent company of High Times®, the most well-known brand in cannabis. This collaboration aims to distribute and market the products initially through High Times' websites and social channels which reach over 10 million people across their owned and operated properties and social media accounts.
With a product launch targeted for Q2 2023, this new line is well-positioned to capitalize on the growing market for psychoactive alternatives, which Forbes predicts will double to over $5 billion in gross sales by 2025.
Lucy and High Times entered into a strategic investment agreement in January whereby Lucy received $2.5 million in advertising credits that will help launch the new brand into market through High Times channels and experiential events.
Chris McElvany, Chief Executive Officer of Lucy Scientific Discovery Inc., stated, “As awareness and acceptance of alternative treatments for various conditions, such as PTSD, anxiety disorders, and depression, continue to grow, adaptogens are emerging as a leading therapeutic remedy. This partnership between Lucy and High Times will enable the two companies to expand the reach of Lucy’s products and promote the potential health benefits to a broader audience.” FULL ARTICLE
Recent IPO report on the first psychedelics manufacturing company to be listed on NASDAQ!
Lucy Scientific Discovery Inc. (NASDAQ: LSDI)
Hot sector, building momentum, low float, great setup
Current price $1.39/share as of market close 03/22/23 Public Float 10.15M Shares (Source: Yahoo Finance)Range Since Inception $1.12 - $4.00/share
About Lucy
Lucy Scientific Discovery Inc. is a Nasdaq-listed (NASDAQ: LSDI) licensed producer of compounds for medicinal products. As granted by Health Canada’s Office of Controlled Substances, Lucy maintains a Controlled Drugs and Substances Dealer’s License, under Part J of the Food and Drug Regulations promulgated under the Food and Drugs Act (Canada), or a Dealer’s License. A Dealer’s License authorizes LSDI to develop, sell, deliver, and manufacture (through extraction or synthesis) certain pharmaceutical-grade active pharmaceutical ingredients, or APIs, used in controlled substances and their raw material precursors.
Here is What Lucy Offers (Source: https://www.lucyscientific.com/)
API and Target Formulation Production
By leveraging various scalable production methods, Lucy is uniquely positioned to effectively support current and future market needs at competitive prices.
Lucy's use of efficient and strategic manufacturing practices ensure a consistent and stable supply of the highest quality products from lab- to consumer-scale.
Research, Development and Commercialization Support
We will work directly with researchers and finished product manufacturers in a controlled and collaborative environment to facilitate healthy market growth.
Our team aims to maximize your probability of success while minimizing the time and costs required to achieve your goals.
Lucy (LSDI) has announced multiple breaking developments since its IPO last month.
LSDI is “focused on becoming the premier contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry”.
The company’s mission is to make their “products and research services available for the development of medicines and experimental therapies to address certain psychiatric health disorders and other medical needs including various mental health and addiction disorders”.
As the company stated in a recent press release:
“The shift toward a public health response to the drug crisis will provide greater opportunities for people who use substances to connect with a growing range of harm reduction and treatment options.”
In addition, as the company explained:
“We look forward to a time when Lucy can safely supply harm reduction programs globally, aiming to reduce lethal and or negative consequences associated with adulterated drug supply, particularly considering that fentanyl overdose is the leading cause of deaths among 18 to 45-year-olds in the United States,” said Chris McElvany, the Company’s CEO.
LSDI is “a licensed manufacturer of controlled compounds dedicated to advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies”.
Furthermore, “The Company has licenses to manufacture several controlled substances, including Psilocybin; MDMA; LSD; Psilocin; N,N-DMT; Mescaline; and 2C-B”.
The company’s team “is composed of leading experts from pharmaceutical development, biotechnology, agriculture, applied chemistry, and consumer product manufacturing industries.”
In addition, the company’s “executive team brings deep experience in the development and commercialization of products featuring controlled substances as well as the navigation of regulatory structures applicable to these products”.
LSDI’s target customers “include an increasing number of the leading universities, hospitals and other public, private, and government institutions throughout the world that have launched research programs to conduct clinical studies aimed at understanding the therapeutic potential of a range of psychedelic substances”.
Recently, the company achieved multiple milestones.
On February 13, the company announced:
“Lucy Scientific Discovery Announces Closing of its $7.5 Million Initial Public Offering”In addition, the company announced:
“Lucy Scientific Discovery to Ring Nasdaq Closing Bell Today in Celebration of its IPO”
Here are the company’s comments from this press release:
“We are excited to celebrate this victory at Nasdaq's iconic bell ringing ceremony, as today marks an important milestone for the Company,” said Chris McElvany, the Company’s CEO. “We are pleased to celebrate many months of hard work and team effort that led to the successful completion of our IPO. Seeing Lucy, a pioneer in psychedelics manufacturing, take the next step in its development by becoming the first psychedelics manufacturing company to be listed on NASDAQ is a huge accomplishment. This milestone marks a significant step in the company's growth and plans for expansion. We look forward to the opportunities ahead of us to continue working on improving mental health and finding sustainable solutions for treatment.”
Afterwards, the company announced another big accomplishment:
“Lucy Scientific Discovery Announces First Commercial Sale of Psilocybin Following Initial Delivery of DMT and 5-MeO-DMT to Hadassah BrainLabs”
Here are the company’s comments from this press release:
“This first commercial sale of psilocybin marks a key operational milestone for the company as we shift from pre revenue to revenue producing, and are excited about further opportunities ahead,” said Lucy’s CEO Chris McElvany. “This transaction establishes Lucy’s ability to supply the global psychedelic community with compounds and services. Not only will it strengthen our relationship with the researchers at Hadassah-Hebrew University Medical Center, whose research helps lay the academic foundations indicating the potential of psychedelics, it will lead to the improvement of lives of millions of people around the world.”
Most recently, on Friday, the company announced another significant development:
“Lucy Scientific Teams Up with Pramantha Group to Secure Key Government Contracts and Grants to Enhance its Manufacturing Capabilities”
As the company further explains:
LSDI “partnered with Pramantha Group, a firm specializing in securing key government contracts and grants, to enhance its drug manufacturing capabilities and meet the growing demand for essential drugs and medical supplies”.
Furthermore:
“By leveraging Pramantha Group's expertise in identifying and capturing strategic funding and contract opportunities, Lucy Scientific is well-positioned to compete for and secure key government contracts and grants. With access to these funds, Lucy Scientific will be able to expand its drug manufacturing capabilities and contribute to the country's healthcare needs.”
Here are some of the company’s comments from this press release:
"Our partnership with Pramantha Group will help us navigate the complex landscape of government contracts and grants and identify the right opportunities to support our growth and contribute to the country's healthcare needs," said Lucy Scientific Discovery’s CEO Chris McElvany. "We are excited to work with Pramantha Group to enhance our drug manufacturing capabilities and play a key role in securing the domestic drug supply. Pramantha has a proven track record and a commitment to excellence that makes it an ideal partner for Lucy as we look to grow our operations."
LSDI has multiple potential catalysts favoring a future of increased growth.
The chart appears to be in bounce mode and is flashing oversold with an RSI of 35.34

https://preview.redd.it/bydiblj3lppa1.png?width=700&format=png&auto=webp&s=cba04c7023a85a4249e0a0bd96434d6804a40f56
A recent report from Data Bridge Market Research said that the psychedelic drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.3% in the forecast period of 2020 to 2027 and expected to reach USD $6,859.95 million by 2027 from USD 2,077.90 million in 2019. Growing acceptance of psychedelic drugs for treating depression and increasing prevalence of depression and mental disorders are the factors for the market growth. Another report from Research And Markets upped the projection saying that the Psychedelic Drugs Market size is projected to reach USD $10.75 Billion by 2027, from USD 4.75 Bn in 2020 growing at a CAGR of 12.36% during 2021-2027.
It is important to note that approximately 70% of the psychedelics market is attributable to psychedelics manufacturers.
To help with your due diligence, here is a comprehensive report on the psychedelics market from Morgan Stanley.
Disclaimer
submitted by SituationLive4406 to StockMarket [link] [comments]


2023.03.24 16:26 SituationLive4406 $LSDI The first psychedelics manufacturing company to be listed on NASDAQ! Low float, building momentum, Recent IPO, Oversold, Looks Ready to Run

$LSDI The first psychedelics manufacturing company to be listed on NASDAQ! Low float, building momentum, Recent IPO, Oversold, Looks Ready to Run
Hello everyone,
Great Partnership News with High Times Out Yesterday!
Lucy Scientific Discovery Announces Partnership with High Times® to Develop and Distribute a New Line of Psychoactive Products
‘Mindful by Lucy’

https://preview.redd.it/6s68ig7egppa1.jpg?width=230&format=pjpg&auto=webp&s=945c9fa8a34b1433d51cc1af8f54c70d865deb57
New Line of Psychoactive Products
VANCOUVER, British Columbia, March 23, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. (“Lucy” or “The Company”) [NASDAQ:LSDI], a leading NASDAQ-listed psychedelic drug manufacturer, announced today the launch of a new line of unscheduled psychoactive compounds that will be available for sale throughout the United States, and where permitted throughout the rest of the world.
The first line in the new family of brands contains Amanita Muscaria mushrooms, a psychoactive adaptogen. The product leverages the compounds of these mushrooms, and a proprietary blend of other natural functional ingredients, to create a transformative experience for consumers worldwide. This product line is named ‘Mindful by Lucy’.
Lucy Scientific will produce Mindful with High Times, through a strategic partnership with Hightimes Holding Corp., the parent company of High Times®, the most well-known brand in cannabis. This collaboration aims to distribute and market the products initially through High Times' websites and social channels which reach over 10 million people across their owned and operated properties and social media accounts.
With a product launch targeted for Q2 2023, this new line is well-positioned to capitalize on the growing market for psychoactive alternatives, which Forbes predicts will double to over $5 billion in gross sales by 2025.
Lucy and High Times entered into a strategic investment agreement in January whereby Lucy received $2.5 million in advertising credits that will help launch the new brand into market through High Times channels and experiential events.
Chris McElvany, Chief Executive Officer of Lucy Scientific Discovery Inc., stated, “As awareness and acceptance of alternative treatments for various conditions, such as PTSD, anxiety disorders, and depression, continue to grow, adaptogens are emerging as a leading therapeutic remedy. This partnership between Lucy and High Times will enable the two companies to expand the reach of Lucy’s products and promote the potential health benefits to a broader audience.” FULL ARTICLE
Recent IPO report on the first psychedelics manufacturing company to be listed on NASDAQ!
Lucy Scientific Discovery Inc. (NASDAQ: LSDI)
Hot sector, building momentum, low float, great setup
Current price $1.39/share as of market close 03/22/23 Public Float 10.15M Shares (Source: Yahoo Finance)Range Since Inception $1.12 - $4.00/share
About Lucy
Lucy Scientific Discovery Inc. is a Nasdaq-listed (NASDAQ: LSDI) licensed producer of compounds for medicinal products. As granted by Health Canada’s Office of Controlled Substances, Lucy maintains a Controlled Drugs and Substances Dealer’s License, under Part J of the Food and Drug Regulations promulgated under the Food and Drugs Act (Canada), or a Dealer’s License. A Dealer’s License authorizes LSDI to develop, sell, deliver, and manufacture (through extraction or synthesis) certain pharmaceutical-grade active pharmaceutical ingredients, or APIs, used in controlled substances and their raw material precursors.
Here is What Lucy Offers (Source: https://www.lucyscientific.com/)
API and Target Formulation Production
By leveraging various scalable production methods, Lucy is uniquely positioned to effectively support current and future market needs at competitive prices.
Lucy's use of efficient and strategic manufacturing practices ensure a consistent and stable supply of the highest quality products from lab- to consumer-scale.
Research, Development and Commercialization Support
We will work directly with researchers and finished product manufacturers in a controlled and collaborative environment to facilitate healthy market growth.
Our team aims to maximize your probability of success while minimizing the time and costs required to achieve your goals.
Lucy (LSDI) has announced multiple breaking developments since its IPO last month.
LSDI is “focused on becoming the premier contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry”.
The company’s mission is to make their “products and research services available for the development of medicines and experimental therapies to address certain psychiatric health disorders and other medical needs including various mental health and addiction disorders”.
As the company stated in a recent press release:
“The shift toward a public health response to the drug crisis will provide greater opportunities for people who use substances to connect with a growing range of harm reduction and treatment options.”
In addition, as the company explained:
“We look forward to a time when Lucy can safely supply harm reduction programs globally, aiming to reduce lethal and or negative consequences associated with adulterated drug supply, particularly considering that fentanyl overdose is the leading cause of deaths among 18 to 45-year-olds in the United States,” said Chris McElvany, the Company’s CEO.
LSDI is “a licensed manufacturer of controlled compounds dedicated to advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies”.
Furthermore, “The Company has licenses to manufacture several controlled substances, including Psilocybin; MDMA; LSD; Psilocin; N,N-DMT; Mescaline; and 2C-B”.
The company’s team “is composed of leading experts from pharmaceutical development, biotechnology, agriculture, applied chemistry, and consumer product manufacturing industries.”
In addition, the company’s “executive team brings deep experience in the development and commercialization of products featuring controlled substances as well as the navigation of regulatory structures applicable to these products”.
LSDI’s target customers “include an increasing number of the leading universities, hospitals and other public, private, and government institutions throughout the world that have launched research programs to conduct clinical studies aimed at understanding the therapeutic potential of a range of psychedelic substances”.
Recently, the company achieved multiple milestones.
On February 13, the company announced:
“Lucy Scientific Discovery Announces Closing of its $7.5 Million Initial Public Offering”In addition, the company announced:
“Lucy Scientific Discovery to Ring Nasdaq Closing Bell Today in Celebration of its IPO”
Here are the company’s comments from this press release:
“We are excited to celebrate this victory at Nasdaq's iconic bell ringing ceremony, as today marks an important milestone for the Company,” said Chris McElvany, the Company’s CEO. “We are pleased to celebrate many months of hard work and team effort that led to the successful completion of our IPO. Seeing Lucy, a pioneer in psychedelics manufacturing, take the next step in its development by becoming the first psychedelics manufacturing company to be listed on NASDAQ is a huge accomplishment. This milestone marks a significant step in the company's growth and plans for expansion. We look forward to the opportunities ahead of us to continue working on improving mental health and finding sustainable solutions for treatment.”
Afterwards, the company announced another big accomplishment:
“Lucy Scientific Discovery Announces First Commercial Sale of Psilocybin Following Initial Delivery of DMT and 5-MeO-DMT to Hadassah BrainLabs”
Here are the company’s comments from this press release:
“This first commercial sale of psilocybin marks a key operational milestone for the company as we shift from pre revenue to revenue producing, and are excited about further opportunities ahead,” said Lucy’s CEO Chris McElvany. “This transaction establishes Lucy’s ability to supply the global psychedelic community with compounds and services. Not only will it strengthen our relationship with the researchers at Hadassah-Hebrew University Medical Center, whose research helps lay the academic foundations indicating the potential of psychedelics, it will lead to the improvement of lives of millions of people around the world.”
Most recently, on Friday, the company announced another significant development:
“Lucy Scientific Teams Up with Pramantha Group to Secure Key Government Contracts and Grants to Enhance its Manufacturing Capabilities”
As the company further explains:
LSDI “partnered with Pramantha Group, a firm specializing in securing key government contracts and grants, to enhance its drug manufacturing capabilities and meet the growing demand for essential drugs and medical supplies”.
Furthermore:
“By leveraging Pramantha Group's expertise in identifying and capturing strategic funding and contract opportunities, Lucy Scientific is well-positioned to compete for and secure key government contracts and grants. With access to these funds, Lucy Scientific will be able to expand its drug manufacturing capabilities and contribute to the country's healthcare needs.”
Here are some of the company’s comments from this press release:
"Our partnership with Pramantha Group will help us navigate the complex landscape of government contracts and grants and identify the right opportunities to support our growth and contribute to the country's healthcare needs," said Lucy Scientific Discovery’s CEO Chris McElvany. "We are excited to work with Pramantha Group to enhance our drug manufacturing capabilities and play a key role in securing the domestic drug supply. Pramantha has a proven track record and a commitment to excellence that makes it an ideal partner for Lucy as we look to grow our operations."
LSDI has multiple potential catalysts favoring a future of increased growth.
RSI of 35.34

https://preview.redd.it/sdlepuufgppa1.png?width=700&format=png&auto=webp&s=c390de69383fb860e2cb25eca917cd0fe3f93f83
A recent report from Data Bridge Market Research said that the psychedelic drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.3% in the forecast period of 2020 to 2027 and expected to reach USD $6,859.95 million by 2027 from USD 2,077.90 million in 2019. Growing acceptance of psychedelic drugs for treating depression and increasing prevalence of depression and mental disorders are the factors for the market growth. Another report from Research And Markets upped the projection saying that the Psychedelic Drugs Market size is projected to reach USD $10.75 Billion by 2027, from USD 4.75 Bn in 2020 growing at a CAGR of 12.36% during 2021-2027.
It is important to note that approximately 70% of the psychedelics market is attributable to psychedelics manufacturers.
To help with your due diligence, here is a comprehensive report on the psychedelics market from Morgan Stanley.
Disclaimer
submitted by SituationLive4406 to MoonBets [link] [comments]


2023.03.24 05:58 Plenty_Ad3169 I have a crush on a guy that I shouldn’t and it’s tearing me apart.

I’ve always been kinda weird. I never fit in at school. I’ve always been a hopeless romantic, but because of some abuse and sexual assaults I experienced when I was 9, the whole attraction thing has been complicated. I’ve never had a guy show me kindness before. My family never showed me kindness. I never had kind friends. All of this changed however when I met a guy at school who I’ll call Jacob. It was the first week of my 7th grade year when I first saw him. It was at a school function and I decided he was the most handsome guy I’d ever seen. I figured that was the last time I’d see him, and I moved on. However, school is a lot smaller that I had realized at the time. I began seeing him every now and then. Then I started looking for him. I told the group of kids I hung out with at the time(I wouldn’t call them friends after some later experiences)about him about a month into school. They immediately knew who I was talking about by the description. They told me his name and, to my horror, the fact that he was a senior. Of course, as bad friends do, they immediately went up to him when my back was turned and told him everything. They showed him who I was and said I had a huge crush on him. He told them he planned to completely ignore me. At that point, I tried to forget him and move on. It was too late at that point though. I began to join clubs and get involved at school, and I accidentally joined most of the things he was doing. I saw him a lot more. I got to know him a lot better. Eventually, I was completely smitten. I’ve always had a bad immune system and miss school a lot. I learned after a while that everyday I missed school, he’d ask a member of my group about me to see if I was okay. And boom. Someone cared about me. I know it was a small gesture, but it meant the world to me. I eventually got desperate to forget about Jacob and began trying for a relationship hoping it would help. I began dating this guy who was sweet at first, but soon became aggressive, to the point I was afraid of him. I dumped him after 2 months, and my mind wondered straight back to Jacob. Last February, I lost both my parents in the span of two weeks. My birthday is in March, so some parents of my peers scraped some money together for a party. I made a joke to my group about inviting Jacob. One of them got the brilliant idea to give him an invitation to embarrass me. I found out through that same person that he declined the invitation because he had work, but he promised to get me something. Two weeks later, I was handed a dollar general bag with some chocolate in it. I was stunned. Another act of kindness. I am aware the party was an act of kindness, but his action was different. It came from a guy I deeply cared about at that time. It came from the first guy to show me kindness. As all things must come to an end, this did too in a way. He graduated. He went off to college. I should’ve stopped then, right? I knew I should’ve pushed him from my mind the day he graduated , but I still can’t. I haven’t seen him for 10 months, yet I think about him every day. I did call him wt the beginning of this school year to check in on him, but it was a 5 minute phone call if that. My current problem is that I’m ready to put myself out there again, but it’s practically impossible because no other guy is Jacob. No other guy has the same sense of humor. No other guy is sweet like him. The list goes on and on. Somewhere deep down I’m afraid I’ll never find love because I can’t find another Jacob, and it hurts. It also hurts because I know he’ll never reciprocate, and it hurts because I know there’s something wrong with me. I just can’t take this feeling anymore. Some concluding inform to make things worse: I’m two grades behind, so I’m actually 15 right now. He’s currently 20, so there’s a 5 year age-gap. He has a girlfriend, and the rumor mill says they’ve been talking marriage.
submitted by Plenty_Ad3169 to Vent [link] [comments]


2023.03.24 05:29 deeplyinsecure2001 I (17m) don’t want to be alone anymore

I’m so sick of it. I’ve never been in a relationship my whole life. Tbf I wasn’t really interested in one until like 7th grade, so the first 12 years weren’t really a struggle, the two years after that weren’t too rough either, but these last couple of years have been rough, especially these past few months.
I found out that this girl liked me. It was like a fever dream to me, it seemed so surreal. I felt things that I had never felt in my whole life. My heart would do this weird sinking thing when I thought about her. We started talking of course. She had a great sense of humor, she was so fucking great.
One week she’s just not so talkative anymore. Same week, she leaves. She tells me it’s not my fault, she just has stuff going on. She told me she wanted to be friends, but I always had to text her first. She never even approached me irl. Tbf I never approached her either, but she dumped me, so I felt like she was disgusted in me. Also I would have made it awkward.
I’ve never been in such pain my whole life. I was so fucking close to knowing what it was like to be that close with somebody, then it just got ripped away from me. I’m the only person I know that the only romantic connection he’s ever had with a girl was a failed talking stage. I never got to go out with her (fucking boarding school), never kissed, only got to stay up talking to each other once. At least I got to love someone I guess.
Apparently she called me a “simp”. I was just really nice. I wouldn’t just bombard her with kindness, but I cared about her deeply, I still do, I just dislike her (I really have no right to but I look at all her negatives as a coping mechanism). I couldn’t believe I wasn’t appreciated. She was one of the last people I ever thought would think negatively of me. I don’t think that was the only reason, she’s going to prom with some other guy, and I never even see them together, so maybe she just wanted something more casual. I’m still hurt, though. I have nobody. People tell me I’m so young and I shouldn’t feel bad, but literally EVERYONE has or has had somebody. All my friends have kissed someone. I’m so sick of it. I’m growing more resentful and negative, which is only hurting me and my chances.
submitted by deeplyinsecure2001 to self [link] [comments]


2023.03.24 02:02 Accomplished_Bat750 I’m an 18-F and he’s an 18-M

okay so this is literally my second reddit post and idk if anyone is gonna see this but anyways. i’ve liked this guy since middle school (i’m in high school rn) and i recently found out he might like me back; here’s some background:
we both went to a catholic private school for 9 years, he was a year older than me, and i always knew he existed. until abt 7th grade i started liking him and have a pretty big crush on him. it was honestly pretty obvious bc i was one of the loud “popular” girls but i never knew for sure if he actually knew. i never got to tell him my feelings bc one of my best friends started dating him. so my friend group had 6 people but only like 3-4 of us were super close. one of those friends was dating this dude, the same grade as my crush, and she convinced my friend to date him (her bf and my crush were best friends) so they could all go on double dates and shit. since i was a bitch back then i created drama and that’s partly what got them together bc they were both mad at me and didn’t care if my feelings were hurt or not.
they all eventually broke up and the two guys graduated and we were all friends again. anyways i kept in touch with my crush somehow every few months. we’d text each other, like sliding up on each other’s stories, talk for a bit and then not talk for another few months. this cycle continued and it continued up until now. honestly every time we talked it felt like not much time passed and there was always something to talked abt.
last winter we started talking again, but since he deleted all his social media we talked on imessage. and we’ve been talking pretty consistently up until now. i’ve always thought he was attractive and never knew whether he thought that way abt me. esp since he dated other people and never really hinted that he had any romantic interest in me. up until pretty recently he started calling me names (like luv and stuff not anything bad😭). and we lowkey been flirting just a little (but idek how to flirt so idk if it actually was flirting or not) and i’ve been getting mixed signals.
so literally a week ago he asked me to add to a playlist he made and i look up the lyrics to the songs and i literally threw my phone. they were love songs and were pretty specific to our situation. and i knew then he thought of me as more than a friend. idk if a friend with benefits, a potential gf, or what but something more than what our relationship has always been. but the problem is he’s talked abt getting girls and mentioned his ex a few times so idk if i’d just be a rebound or what.
we both live in separate states and i’m planning on visiting my brother this summer in that state and also seeing this guy. but i don’t want to get my hopes up and be let down. i also don’t want him to play me and my heart gets broken. bc this dude is so attractive, we have sm things in common, and she share similar values. like we have goals and both work on self-improvement so idk if this is all fake, if i’m getting my hopes up, if i’m looking at him thru rose-colored lenses, or what. but i can’t talk to anyone abt this: my parents, def not my brother who said he’ll beat up any guy in talking to, and i don’t have many friends, esp those that aren’t fake. it’s really frustrating bc i’ve always tried to work my feelings out by myself but i can’t talk to anyone abt it or ask for any advice. that’s exactly why i’m on reddit ranting abt this. so if someone could offer their opinion or some advice i’d greatly appreciate it. i’m super bad at storytelling so if there’s anything confusing i’ll try to reply or edit this to clarify anything. :)
submitted by Accomplished_Bat750 to relationship_advice [link] [comments]


2023.03.23 23:07 Then_Marionberry_259 MAR 23, 2023 LUN.TO LUNDIN MINING ANNOUNCES APPOINTMENT OF MARIA OLIVIA RECART TO BOARD OF DIRECTORS

MAR 23, 2023 LUN.TO LUNDIN MINING ANNOUNCES APPOINTMENT OF MARIA OLIVIA RECART TO BOARD OF DIRECTORS
https://preview.redd.it/eck2zm04bkpa1.png?width=3500&format=png&auto=webp&s=8e6c32bb72224bc2639010dffb72b2d56ce42f82
https://preview.redd.it/nopifx34bkpa1.jpg?width=400&format=pjpg&auto=webp&s=40cc0b7783a224337d86c13ed57ded3f0c20b81f
TORONTO , March 23, 2023 /CNW/ - (TSX: LUN) (Nasdaq Stockholm: LUMI) Lundin Mining Corporation ("Lundin Mining" or the "Company") is pleased to announce the appointment of Maria Olivia Recart to the Company's Board of Directors (the "Board") effective today.
"We are excited to welcome Maria Olivia Recart to the Lundin Mining team and Board," commented Adam Lundin , Chair of Lundin Mining's Board of Directors. Peter Rockandel , CEO, added, " Maria Olivia's extensive knowledge, experience and recognized contributions in Chile make for an ideal addition to our Board. Her wealth of expertise rooted in experience on many environmental and social topics, including community engagement, government relations, sustainable supply chains and social values will provide invaluable perspective."
Most recently,
Maria Olivia
was the Dean of Universidad Santo Tomás from 2019 to 2023, prior to which, she worked at BHP from 2010 to 2018 as Vice President ("VP") Corporate Affairs. As VP of Corporate Affairs for BHP, she was responsible for community engagement, communications, government relations and social value strategy for the Americas. During that time, she also served as a member of the Owners' Council of BHP's Escondida mine, where she advised on a range of operational, safety, financial, commercial, human resources and strategy issues. She was also appointed as VP of the board of directors of Fundación
Chile
, a mixed board composed of Chilean government officials and BHP appointed professionals; VP of Centro de Entrenamiento Industrial y Minero, an apprentice learning center to promote the skills needed in the workforce for productivity impact in mining and construction operations; and VP of Fundación Minera Escondida, a non-profit organization in the region of
Antofagasta
whose initiatives are focused on making an impact in the region's human and social capital and target minorities, the indigenous communities and women in particular.
Maria Olivia
also has experience in the public sector in
Chile
, where she served as Vice Minister of Finance between 2006 and 2010 and was responsible for the team that led
Chile
into the Organization for Economic Co-operation and Development.
About Lundin Mining
Lundin Mining is a diversified Canadian base metals mining company with projects and operations in Argentina , Brazil , Chile , Portugal , Sweden and the United States of America , primarily producing copper, zinc, gold and nickel.
The information in this release is subject to the disclosure requirements of Lundin Mining under the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out below on March 23, 2023 at 16:30 Eastern Time
Cautionary Statement on Forward-Looking Information
Certain of the statements made and information contained herein is "forward-looking information" within the meaning of applicable Canadian securities laws. All statements other than statements of historical facts included in this document constitute forward-looking information, including but not limited to statements regarding the Company's plans, prospects and business strategies; the Company's guidance on the timing and amount of future production and its expectations regarding the results of operations; expected costs; permitting requirements and timelines; timing and possible outcome of pending litigation; the results of any Preliminary Economic Assessment, Feasibility Study, or Mineral Resource and Mineral Reserve estimations, life of mine estimates, and mine and mine closure plans; anticipated market prices of metals, currency exchange rates, and interest rates; the development and implementation of the Company's Responsible Mining Management System; the Company's ability to comply with contractual and permitting or other regulatory requirements; anticipated exploration and development activities at the Company's projects; the Company's integration of acquisitions and any anticipated benefits thereof; and expectations for other economic, business, and/or competitive factors. Words such as "believe", "expect", "anticipate", "contemplate", "target", "plan", "goal", "aim", "intend", "continue", "budget", "estimate", "may", "will", "can", "could", "should", "schedule" and similar expressions identify forward-looking statements.
Forward-looking information is necessarily based upon various estimates and assumptions including, without limitation, the expectations and beliefs of management, including that the Company can access financing, appropriate equipment and sufficient labour; assumed and future price of copper, nickel, zinc, gold and other metals; anticipated costs; ability to achieve goals; the prompt and effective integration of acquisitions; that the political environment in which the Company operates will continue to support the development and operation of mining projects; and assumptions related to the factors set forth below. While these factors and assumptions are considered reasonable by Lundin Mining as at the date of this document in light of management's experience and perception of current conditions and expected developments, these statements are inherently subject to significant business, economic and competitive uncertainties and contingencies. Known and unknown factors could cause actual results to differ materially from those projected in the forward-looking statements and undue reliance should not be placed on such statements and information. Such factors include, but are not limited to: global financial conditions, market volatility and inflation, including pricing and availability of key supplies and services; risks inherent in mining including but not limited to risks to the environment, industrial accidents, catastrophic equipment failures, unusual or unexpected geological formations or unstable ground conditions, and natural phenomena such as earthquakes, flooding or unusually severe weather; uninsurable risks; project financing risks, liquidity risks and limited financial resources; volatility and fluctuations in metal and commodity demand and prices; delays or the inability to obtain, retain or comply with permits; significant reliance on a single asset; reputation risks related to negative publicity with respect to the Company or the mining industry in general; health and safety risks; risks relating to the development of the Josemaria Project; inability to attract and retain highly skilled employees; risks associated with climate change; compliance with environmental, health and safety laws and regulations; unavailable or inaccessible infrastructure, infrastructure failures, and risks related to ageing infrastructure; risks inherent in and/or associated with operating in foreign countries and emerging markets, including with respect to foreign exchange and capital controls; economic, political and social instability and mining regime changes in the Company's operating jurisdictions, including but not limited to those related to permitting and approvals, environmental and tailings management, labour, trade relations, and transportation; risks relating to indebtedness; the inability to effectively compete in the industry; risks associated with acquisitions and related integration efforts, including the ability to achieve anticipated benefits, unanticipated difficulties or expenditures relating to integration and diversion of management time on integration; changing taxation regimes; risks related to mine closure activities, reclamation obligations, environmental liabilities and closed and historical sites; reliance on key personnel and reporting and oversight systems, as well as third parties and consultants in foreign jurisdictions; information technology and cybersecurity risks; risks associated with the estimation of Mineral Resources and Mineral Reserves and the geology, grade and continuity of mineral deposits including but not limited to models relating thereto; actual ore mined and/or metal recoveries varying from Mineral Resource and Mineral Reserve estimates, estimates of grade, tonnage, dilution, mine plans and metallurgical and other characteristics; ore processing efficiency; community and stakeholder opposition; financial projections, including estimates of future expenditures and cash costs, and estimates of future production may not be reliable; enforcing legal rights in foreign jurisdictions; environmental and regulatory risks associated with the structural stability of waste rock dumps or tailings storage facilities; activist shareholders and proxy solicitation matters; risks relating to dilution; regulatory investigations, enforcement, sanctions and/or related or other litigation; risks relating to payment of dividends; counterparty and customer concentration risks; the estimation of asset carrying values; risks associated with the use of derivatives; relationships with employees and contractors, and the potential for and effects of labour disputes or other unanticipated difficulties with or shortages of labour or interruptions in production; conflicts of interest; existence of a significant shareholder; exchange rate fluctuations; challenges or defects in title; internal controls; compliance with foreign laws; potential for the allegation of fraud and corruption involving the Company, its customers, suppliers or employees, or the allegation of improper or discriminatory employment practices, or human rights violations; the threat associated with outbreaks of viruses and infectious diseases; risks relating to minor elements contained in concentrate products; and other risks and uncertainties, including but not limited to those described in the "Risk and Uncertainties" section of the Company's Annual Information Form and the "Managing Risks" section of the Company's MD&A for the year ended December 31, 2022 , which are available on SEDAR at [www.sedar.com*](http://www.sedar.com) under the Company's profile. All of the forward-looking statements made in this document are qualified by these cautionary statements. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated, forecast or intended and readers are cautioned that the foregoing list is not exhaustive of all factors and assumptions which may have been used. Should one or more of these risks and uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in forward-looking information. Accordingly, there can be no assurance that forward-looking information will prove to be accurate and forward-looking information is not a guarantee of future performance. Readers are advised not to place undue reliance on forward-looking information. The forward-looking information contained herein speaks only as of the date of this document. The Company disclaims any intention or obligation to update or revise forward–looking information or to explain any material difference between such and subsequent actual events, except as required by applicable law.*
Lundin Mining Announces Appointment of Maria Olivia Recart to Board of Directors (CNW Group/Lundin Mining Corporation)
SOURCE Lundin Mining Corporation

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/March2023/23/c8646.html
https://preview.redd.it/jqoq5z44bkpa1.png?width=4000&format=png&auto=webp&s=fc7004f59de4212ac10fd85010c192f1463f4bc7
Universal Site Links
LUNDIN MINING CORP.
STOCK METAL DATABASE
ADD TICKER TO THE DATABASE
www.reddit.com/Treaty_Creek
REPORT AN ERROR
submitted by Then_Marionberry_259 to Treaty_Creek [link] [comments]


2023.03.23 22:27 Plantmom1313 How to deal w a toxic friend

TW: Sexual Assault
I (22F) need advice on how to deal w a longtime friend (22F). For some background we have been very close friends since 7th grade, and have only gone one period of not talking, approx a year because she had an extremely toxic/abusive ex boyfriend. Now to get to the current problem, I think it boils down to the fact that she is extremely not self aware.
I myself have been with my current boyfriend for 5 years and it’s by far the best relationship I could ask for. She on the other hand has not had a boyfriend since her toxic ex and often just uses dating apps but finds only guys who basically treat her like shit, and she lets it happen. Now, she is seeing a guy who I, as well as the rest of her friends have made clear we don’t like, since he also treats her like shit, but she doesn’t see it like that. This guy is somebody who I have known for as long as I’ve known her, but haven’t talked to him since highschool.
Well, I was raped in hs at 15 by a guy I thought was one of my best friends. But instead he raped me, and bragged to people that he slept with me and I never had the courage to tell anybody but a couple very close friends and my boyfriend, to this day my family does not know, and I’m still extremely traumatized from the experience. She is one of the few people that knows. NOW, she is seeing a guy, who is friends with my rapist. She went to a birthday party for the guy she’s seeing and my rapist was there, and what did she decide to do. Go outside and smoke with him and his new girlfriend. When I tried expressing how angry I was, she tried telling me “he seems like a changed person now.” That will never fly with me, and I’m not sure if it’s something I can get past.
Then last spring break she gave me, my boyfriend, and his whole family covid. Now this spring break she had the flu, she texted and asked if she picked me up if I would run errands with her. I replied “I love you, but I’m not trying to get the flu.” She didn’t respond, but immediately called me to yell at me how she doesn’t have the flu anymore and was overall just being a complete bitch. We haven’t talked since, until this morning when she texted me “I’m sorry Imy” with a sad face. I haven’t responded, I don’t know what to say, I don’t know what to do moving forward. Please help!
submitted by Plantmom1313 to Advice [link] [comments]


2023.03.23 18:07 StocksonHighAlertz NASDAQ $LSDI Licensed Manufacturer & Supplier of Psychedelics

NASDAQ $LSDI Licensed Manufacturer & Supplier of Psychedelics
Hello everyone and welcome to all our new members,
As mentioned yesterday, you're joining us at a great time. Here's why...
We have a recent IPO report on the first psychedelics manufacturing company to be listed on NASDAQ!
Lucy Scientific Discovery Inc. (NASDAQ: LSDI)
Hot sector, building momentum, low float, great setup
Current price $1.39/share as of market close 03/22/23 Public Float 10.15M Shares (Source: Yahoo Finance)Range Since Inception $1.12 - $4.00/share
About Lucy
Lucy Scientific Discovery Inc. is a Nasdaq-listed (NASDAQ: LSDI) licensed producer of compounds for medicinal products. As granted by Health Canada’s Office of Controlled Substances, Lucy maintains a Controlled Drugs and Substances Dealer’s License, under Part J of the Food and Drug Regulations promulgated under the Food and Drugs Act (Canada), or a Dealer’s License. A Dealer’s License authorizes LSDI to develop, sell, deliver, and manufacture (through extraction or synthesis) certain pharmaceutical-grade active pharmaceutical ingredients, or APIs, used in controlled substances and their raw material precursors.

Here is What Lucy Offers (Source: https://www.lucyscientific.com/)
API and Target Formulation Production
By leveraging various scalable production methods, Lucy is uniquely positioned to effectively support current and future market needs at competitive prices.
Lucy's use of efficient and strategic manufacturing practices ensure a consistent and stable supply of the highest quality products from lab- to consumer-scale.
Research, Development and Commercialization Support
We will work directly with researchers and finished product manufacturers in a controlled and collaborative environment to facilitate healthy market growth.
Our team aims to maximize your probability of success while minimizing the time and costs required to achieve your goals.
Lucy (LSDI) has announced multiple breaking developments since its IPO last month.
LSDI is “focused on becoming the premier contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry”.
The company’s mission is to make their “products and research services available for the development of medicines and experimental therapies to address certain psychiatric health disorders and other medical needs including various mental health and addiction disorders”.
As the company stated in a recent press release:
“The shift toward a public health response to the drug crisis will provide greater opportunities for people who use substances to connect with a growing range of harm reduction and treatment options.”
In addition, as the company explained:
“We look forward to a time when Lucy can safely supply harm reduction programs globally, aiming to reduce lethal and or negative consequences associated with adulterated drug supply, particularly considering that fentanyl overdose is the leading cause of deaths among 18 to 45-year-olds in the United States,” said Chris McElvany, the Company’s CEO.
LSDI is “a licensed manufacturer of controlled compounds dedicated to advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies”.
Furthermore, “The Company has licenses to manufacture several controlled substances, including Psilocybin; MDMA; LSD; Psilocin; N,N-DMT; Mescaline; and 2C-B”.
The company’s team “is composed of leading experts from pharmaceutical development, biotechnology, agriculture, applied chemistry, and consumer product manufacturing industries.”
In addition, the company’s “executive team brings deep experience in the development and commercialization of products featuring controlled substances as well as the navigation of regulatory structures applicable to these products”.
LSDI’s target customers “include an increasing number of the leading universities, hospitals and other public, private, and government institutions throughout the world that have launched research programs to conduct clinical studies aimed at understanding the therapeutic potential of a range of psychedelic substances”.
Recently, the company achieved multiple milestones.
On February 13, the company announced:
“Lucy Scientific Discovery Announces Closing of its $7.5 Million Initial Public Offering” In addition, the company announced:
“Lucy Scientific Discovery to Ring Nasdaq Closing Bell Today in Celebration of its IPO”
Here are the company’s comments from this press release:
“We are excited to celebrate this victory at Nasdaq's iconic bell ringing ceremony, as today marks an important milestone for the Company,” said Chris McElvany, the Company’s CEO. “We are pleased to celebrate many months of hard work and team effort that led to the successful completion of our IPO. Seeing Lucy, a pioneer in psychedelics manufacturing, take the next step in its development by becoming the first psychedelics manufacturing company to be listed on NASDAQ is a huge accomplishment. This milestone marks a significant step in the company's growth and plans for expansion. We look forward to the opportunities ahead of us to continue working on improving mental health and finding sustainable solutions for treatment.”
Afterwards, the company announced another big accomplishment:
“Lucy Scientific Discovery Announces First Commercial Sale of Psilocybin Following Initial Delivery of DMT and 5-MeO-DMT to Hadassah BrainLabs”
Here are the company’s comments from this press release:
“This first commercial sale of psilocybin marks a key operational milestone for the company as we shift from pre revenue to revenue producing, and are excited about further opportunities ahead,” said Lucy’s CEO Chris McElvany. “This transaction establishes Lucy’s ability to supply the global psychedelic community with compounds and services. Not only will it strengthen our relationship with the researchers at Hadassah-Hebrew University Medical Center, whose research helps lay the academic foundations indicating the potential of psychedelics, it will lead to the improvement of lives of millions of people around the world.”
Most recently, on Friday, the company announced another significant development:
“Lucy Scientific Teams Up with Pramantha Group to Secure Key Government Contracts and Grants to Enhance its Manufacturing Capabilities”
As the company further explains:
LSDI “partnered with Pramantha Group, a firm specializing in securing key government contracts and grants, to enhance its drug manufacturing capabilities and meet the growing demand for essential drugs and medical supplies”.
Furthermore:
“By leveraging Pramantha Group's expertise in identifying and capturing strategic funding and contract opportunities, Lucy Scientific is well-positioned to compete for and secure key government contracts and grants. With access to these funds, Lucy Scientific will be able to expand its drug manufacturing capabilities and contribute to the country's healthcare needs.”
Here are some of the company’s comments from this press release:
"Our partnership with Pramantha Group will help us navigate the complex landscape of government contracts and grants and identify the right opportunities to support our growth and contribute to the country's healthcare needs," said Lucy Scientific Discovery’s CEO Chris McElvany. "We are excited to work with Pramantha Group to enhance our drug manufacturing capabilities and play a key role in securing the domestic drug supply. Pramantha has a proven track record and a commitment to excellence that makes it an ideal partner for Lucy as we look to grow our operations."
LSDI has multiple potential catalysts favoring a future of increased growth.
The chart appears to be in bounce mode and is flashing oversold with an RSI of 35.34



A recent report from Data Bridge Market Research said that the psychedelic drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.3% in the forecast period of 2020 to 2027 and expected to reach USD $6,859.95 million by 2027 from USD 2,077.90 million in 2019. Growing acceptance of psychedelic drugs for treating depression and increasing prevalence of depression and mental disorders are the factors for the market growth. Another report from Research And Markets upped the projection saying that the Psychedelic Drugs Market size is projected to reach USD $10.75 Billion by 2027, from USD 4.75 Bn in 2020 growing at a CAGR of 12.36% during 2021-2027.
It is important to note that approximately 70% of the psychedelics market is attributable to psychedelics manufacturers.
To help with your due diligence, here is a comprehensive report on the psychedelics market from Morgan Stanley.
We will have an updated report on (LSDI) soon,
The Team https://mailchi.mp/broadstreetalerts/lsdi-licensed-manufacturer-supplier-of-psychedelics?e=[UNIQID]
submitted by StocksonHighAlertz to StocksMarket [link] [comments]


2023.03.23 16:17 StocksonHighAlertz NASDAQ $LSDI Licensed Manufacturer & Supplier of Psychedelics

NASDAQ $LSDI Licensed Manufacturer & Supplier of Psychedelics
Hello everyone and welcome to all our new members,
As mentioned yesterday, you're joining us at a great time. Here's why...
We have a recent IPO report on the first psychedelics manufacturing company to be listed on NASDAQ!
Lucy Scientific Discovery Inc. (NASDAQ: LSDI)
Hot sector, building momentum, low float, great setup
Current price $1.39/share as of market close 03/22/23 Public Float 10.15M Shares (Source: Yahoo Finance)Range Since Inception $1.12 - $4.00/share
About Lucy
Lucy Scientific Discovery Inc. is a Nasdaq-listed (NASDAQ: LSDI) licensed producer of compounds for medicinal products. As granted by Health Canada’s Office of Controlled Substances, Lucy maintains a Controlled Drugs and Substances Dealer’s License, under Part J of the Food and Drug Regulations promulgated under the Food and Drugs Act (Canada), or a Dealer’s License. A Dealer’s License authorizes LSDI to develop, sell, deliver, and manufacture (through extraction or synthesis) certain pharmaceutical-grade active pharmaceutical ingredients, or APIs, used in controlled substances and their raw material precursors.

Here is What Lucy Offers (Source: https://www.lucyscientific.com/)
API and Target Formulation Production
By leveraging various scalable production methods, Lucy is uniquely positioned to effectively support current and future market needs at competitive prices.
Lucy's use of efficient and strategic manufacturing practices ensure a consistent and stable supply of the highest quality products from lab- to consumer-scale.
Research, Development and Commercialization Support
We will work directly with researchers and finished product manufacturers in a controlled and collaborative environment to facilitate healthy market growth.
Our team aims to maximize your probability of success while minimizing the time and costs required to achieve your goals.
Lucy (LSDI) has announced multiple breaking developments since its IPO last month.
LSDI is “focused on becoming the premier contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry”.
The company’s mission is to make their “products and research services available for the development of medicines and experimental therapies to address certain psychiatric health disorders and other medical needs including various mental health and addiction disorders”.
As the company stated in a recent press release:
“The shift toward a public health response to the drug crisis will provide greater opportunities for people who use substances to connect with a growing range of harm reduction and treatment options.”
In addition, as the company explained:
“We look forward to a time when Lucy can safely supply harm reduction programs globally, aiming to reduce lethal and or negative consequences associated with adulterated drug supply, particularly considering that fentanyl overdose is the leading cause of deaths among 18 to 45-year-olds in the United States,” said Chris McElvany, the Company’s CEO.
LSDI is “a licensed manufacturer of controlled compounds dedicated to advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies”.
Furthermore, “The Company has licenses to manufacture several controlled substances, including Psilocybin; MDMA; LSD; Psilocin; N,N-DMT; Mescaline; and 2C-B”.
The company’s team “is composed of leading experts from pharmaceutical development, biotechnology, agriculture, applied chemistry, and consumer product manufacturing industries.”
In addition, the company’s “executive team brings deep experience in the development and commercialization of products featuring controlled substances as well as the navigation of regulatory structures applicable to these products”.
LSDI’s target customers “include an increasing number of the leading universities, hospitals and other public, private, and government institutions throughout the world that have launched research programs to conduct clinical studies aimed at understanding the therapeutic potential of a range of psychedelic substances”.
Recently, the company achieved multiple milestones.
On February 13, the company announced:
“Lucy Scientific Discovery Announces Closing of its $7.5 Million Initial Public Offering” In addition, the company announced:
“Lucy Scientific Discovery to Ring Nasdaq Closing Bell Today in Celebration of its IPO”
Here are the company’s comments from this press release:
“We are excited to celebrate this victory at Nasdaq's iconic bell ringing ceremony, as today marks an important milestone for the Company,” said Chris McElvany, the Company’s CEO. “We are pleased to celebrate many months of hard work and team effort that led to the successful completion of our IPO. Seeing Lucy, a pioneer in psychedelics manufacturing, take the next step in its development by becoming the first psychedelics manufacturing company to be listed on NASDAQ is a huge accomplishment. This milestone marks a significant step in the company's growth and plans for expansion. We look forward to the opportunities ahead of us to continue working on improving mental health and finding sustainable solutions for treatment.”
Afterwards, the company announced another big accomplishment:
“Lucy Scientific Discovery Announces First Commercial Sale of Psilocybin Following Initial Delivery of DMT and 5-MeO-DMT to Hadassah BrainLabs”
Here are the company’s comments from this press release:
“This first commercial sale of psilocybin marks a key operational milestone for the company as we shift from pre revenue to revenue producing, and are excited about further opportunities ahead,” said Lucy’s CEO Chris McElvany. “This transaction establishes Lucy’s ability to supply the global psychedelic community with compounds and services. Not only will it strengthen our relationship with the researchers at Hadassah-Hebrew University Medical Center, whose research helps lay the academic foundations indicating the potential of psychedelics, it will lead to the improvement of lives of millions of people around the world.”
Most recently, on Friday, the company announced another significant development:
“Lucy Scientific Teams Up with Pramantha Group to Secure Key Government Contracts and Grants to Enhance its Manufacturing Capabilities”
As the company further explains:
LSDI “partnered with Pramantha Group, a firm specializing in securing key government contracts and grants, to enhance its drug manufacturing capabilities and meet the growing demand for essential drugs and medical supplies”.
Furthermore:
“By leveraging Pramantha Group's expertise in identifying and capturing strategic funding and contract opportunities, Lucy Scientific is well-positioned to compete for and secure key government contracts and grants. With access to these funds, Lucy Scientific will be able to expand its drug manufacturing capabilities and contribute to the country's healthcare needs.”
Here are some of the company’s comments from this press release:
"Our partnership with Pramantha Group will help us navigate the complex landscape of government contracts and grants and identify the right opportunities to support our growth and contribute to the country's healthcare needs," said Lucy Scientific Discovery’s CEO Chris McElvany. "We are excited to work with Pramantha Group to enhance our drug manufacturing capabilities and play a key role in securing the domestic drug supply. Pramantha has a proven track record and a commitment to excellence that makes it an ideal partner for Lucy as we look to grow our operations."
LSDI has multiple potential catalysts favoring a future of increased growth.
The chart appears to be in bounce mode and is flashing oversold with an RSI of 35.34



A recent report from Data Bridge Market Research said that the psychedelic drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.3% in the forecast period of 2020 to 2027 and expected to reach USD $6,859.95 million by 2027 from USD 2,077.90 million in 2019. Growing acceptance of psychedelic drugs for treating depression and increasing prevalence of depression and mental disorders are the factors for the market growth. Another report from Research And Markets upped the projection saying that the Psychedelic Drugs Market size is projected to reach USD $10.75 Billion by 2027, from USD 4.75 Bn in 2020 growing at a CAGR of 12.36% during 2021-2027.
It is important to note that approximately 70% of the psychedelics market is attributable to psychedelics manufacturers.
To help with your due diligence, here is a comprehensive report on the psychedelics market from Morgan Stanley.
We will have an updated report on (LSDI) soon,
The Team https://mailchi.mp/broadstreetalerts/lsdi-licensed-manufacturer-supplier-of-psychedelics?e=[UNIQID]
submitted by StocksonHighAlertz to smallstreetbets [link] [comments]


2023.03.23 15:43 StocksonHighAlertz NASDAQ $LSDI Licensed Manufacturer & Supplier of Psychedelics

Hello everyone and welcome to all our new members,
As mentioned yesterday, you're joining us at a great time. Here's why...
We have a recent IPO report on the first psychedelics manufacturing company to be listed on NASDAQ!
Lucy Scientific Discovery Inc. (NASDAQ: LSDI)
Hot sector, building momentum, low float, great setup
Current price $1.39/share as of market close 03/22/23 Public Float 10.15M Shares (Source: Yahoo Finance)Range Since Inception $1.12 - $4.00/share
About Lucy
Lucy Scientific Discovery Inc. is a Nasdaq-listed (NASDAQ: LSDI) licensed producer of compounds for medicinal products. As granted by Health Canada’s Office of Controlled Substances, Lucy maintains a Controlled Drugs and Substances Dealer’s License, under Part J of the Food and Drug Regulations promulgated under the Food and Drugs Act (Canada), or a Dealer’s License. A Dealer’s License authorizes LSDI to develop, sell, deliver, and manufacture (through extraction or synthesis) certain pharmaceutical-grade active pharmaceutical ingredients, or APIs, used in controlled substances and their raw material precursors.

Here is What Lucy Offers (Source: https://www.lucyscientific.com/)
API and Target Formulation Production
By leveraging various scalable production methods, Lucy is uniquely positioned to effectively support current and future market needs at competitive prices.
Lucy's use of efficient and strategic manufacturing practices ensure a consistent and stable supply of the highest quality products from lab- to consumer-scale.
Research, Development and Commercialization Support
We will work directly with researchers and finished product manufacturers in a controlled and collaborative environment to facilitate healthy market growth.
Our team aims to maximize your probability of success while minimizing the time and costs required to achieve your goals.
Lucy (LSDI) has announced multiple breaking developments since its IPO last month.
LSDI is “focused on becoming the premier contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry”.
The company’s mission is to make their “products and research services available for the development of medicines and experimental therapies to address certain psychiatric health disorders and other medical needs including various mental health and addiction disorders”.
As the company stated in a recent press release:
“The shift toward a public health response to the drug crisis will provide greater opportunities for people who use substances to connect with a growing range of harm reduction and treatment options.”
In addition, as the company explained:
“We look forward to a time when Lucy can safely supply harm reduction programs globally, aiming to reduce lethal and or negative consequences associated with adulterated drug supply, particularly considering that fentanyl overdose is the leading cause of deaths among 18 to 45-year-olds in the United States,” said Chris McElvany, the Company’s CEO.
LSDI is “a licensed manufacturer of controlled compounds dedicated to advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies”.
Furthermore, “The Company has licenses to manufacture several controlled substances, including Psilocybin; MDMA; LSD; Psilocin; N,N-DMT; Mescaline; and 2C-B”.
The company’s team “is composed of leading experts from pharmaceutical development, biotechnology, agriculture, applied chemistry, and consumer product manufacturing industries.”
In addition, the company’s “executive team brings deep experience in the development and commercialization of products featuring controlled substances as well as the navigation of regulatory structures applicable to these products”.
LSDI’s target customers “include an increasing number of the leading universities, hospitals and other public, private, and government institutions throughout the world that have launched research programs to conduct clinical studies aimed at understanding the therapeutic potential of a range of psychedelic substances”.
Recently, the company achieved multiple milestones.
On February 13, the company announced:
“Lucy Scientific Discovery Announces Closing of its $7.5 Million Initial Public Offering” In addition, the company announced:
“Lucy Scientific Discovery to Ring Nasdaq Closing Bell Today in Celebration of its IPO”
Here are the company’s comments from this press release:
“We are excited to celebrate this victory at Nasdaq's iconic bell ringing ceremony, as today marks an important milestone for the Company,” said Chris McElvany, the Company’s CEO. “We are pleased to celebrate many months of hard work and team effort that led to the successful completion of our IPO. Seeing Lucy, a pioneer in psychedelics manufacturing, take the next step in its development by becoming the first psychedelics manufacturing company to be listed on NASDAQ is a huge accomplishment. This milestone marks a significant step in the company's growth and plans for expansion. We look forward to the opportunities ahead of us to continue working on improving mental health and finding sustainable solutions for treatment.”
Afterwards, the company announced another big accomplishment:
“Lucy Scientific Discovery Announces First Commercial Sale of Psilocybin Following Initial Delivery of DMT and 5-MeO-DMT to Hadassah BrainLabs”
Here are the company’s comments from this press release:
“This first commercial sale of psilocybin marks a key operational milestone for the company as we shift from pre revenue to revenue producing, and are excited about further opportunities ahead,” said Lucy’s CEO Chris McElvany. “This transaction establishes Lucy’s ability to supply the global psychedelic community with compounds and services. Not only will it strengthen our relationship with the researchers at Hadassah-Hebrew University Medical Center, whose research helps lay the academic foundations indicating the potential of psychedelics, it will lead to the improvement of lives of millions of people around the world.”
Most recently, on Friday, the company announced another significant development:
“Lucy Scientific Teams Up with Pramantha Group to Secure Key Government Contracts and Grants to Enhance its Manufacturing Capabilities”
As the company further explains:
LSDI “partnered with Pramantha Group, a firm specializing in securing key government contracts and grants, to enhance its drug manufacturing capabilities and meet the growing demand for essential drugs and medical supplies”.
Furthermore:
“By leveraging Pramantha Group's expertise in identifying and capturing strategic funding and contract opportunities, Lucy Scientific is well-positioned to compete for and secure key government contracts and grants. With access to these funds, Lucy Scientific will be able to expand its drug manufacturing capabilities and contribute to the country's healthcare needs.”
Here are some of the company’s comments from this press release:
"Our partnership with Pramantha Group will help us navigate the complex landscape of government contracts and grants and identify the right opportunities to support our growth and contribute to the country's healthcare needs," said Lucy Scientific Discovery’s CEO Chris McElvany. "We are excited to work with Pramantha Group to enhance our drug manufacturing capabilities and play a key role in securing the domestic drug supply. Pramantha has a proven track record and a commitment to excellence that makes it an ideal partner for Lucy as we look to grow our operations."
LSDI has multiple potential catalysts favoring a future of increased growth.
The chart appears to be in bounce mode and is flashing oversold with an RSI of 35.34
A recent report from Data Bridge Market Research said that the psychedelic drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.3% in the forecast period of 2020 to 2027 and expected to reach USD $6,859.95 million by 2027 from USD 2,077.90 million in 2019. Growing acceptance of psychedelic drugs for treating depression and increasing prevalence of depression and mental disorders are the factors for the market growth. Another report from Research And Markets upped the projection saying that the Psychedelic Drugs Market size is projected to reach USD $10.75 Billion by 2027, from USD 4.75 Bn in 2020 growing at a CAGR of 12.36% during 2021-2027.
It is important to note that approximately 70% of the psychedelics market is attributable to psychedelics manufacturers.
To help with your due diligence, here is a comprehensive report on the psychedelics market from Morgan Stanley.
We will have an updated report on (LSDI) soon,
The Team https://mailchi.mp/broadstreetalerts/lsdi-licensed-manufacturer-supplier-of-psychedelics?e=[UNIQID]
submitted by StocksonHighAlertz to PennyStocksDD [link] [comments]


2023.03.23 15:00 StocksonHighAlertz NASDAQ $LSDI Licensed Manufacturer & Supplier of Psychedelics

Hello everyone and welcome to all our new members,
As mentioned yesterday, you're joining us at a great time. Here's why...
We have a recent IPO report on the first psychedelics manufacturing company to be listed on NASDAQ!
Lucy Scientific Discovery Inc. (NASDAQ: LSDI)
Hot sector, building momentum, low float, great setup
Current price $1.39/share as of market close 03/22/23 Public Float 10.15M Shares (Source: Yahoo Finance) Range Since Inception $1.12 - $4.00/share
About Lucy
Lucy Scientific Discovery Inc. is a Nasdaq-listed (NASDAQ: LSDI) licensed producer of compounds for medicinal products. As granted by Health Canada’s Office of Controlled Substances, Lucy maintains a Controlled Drugs and Substances Dealer’s License, under Part J of the Food and Drug Regulations promulgated under the Food and Drugs Act (Canada), or a Dealer’s License. A Dealer’s License authorizes LSDI to develop, sell, deliver, and manufacture (through extraction or synthesis) certain pharmaceutical-grade active pharmaceutical ingredients, or APIs, used in controlled substances and their raw material precursors.
Here is What Lucy Offers (Source: https://www.lucyscientific.com/)
API and Target Formulation Production
By leveraging various scalable production methods, Lucy is uniquely positioned to effectively support current and future market needs at competitive prices.
Lucy's use of efficient and strategic manufacturing practices ensure a consistent and stable supply of the highest quality products from lab- to consumer-scale.
Research, Development and Commercialization Support
We will work directly with researchers and finished product manufacturers in a controlled and collaborative environment to facilitate healthy market growth.
Our team aims to maximize your probability of success while minimizing the time and costs required to achieve your goals.
Lucy (LSDI) has announced multiple breaking developments since its IPO last month.
LSDI is “focused on becoming the premier contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry”.
The company’s mission is to make their “products and research services available for the development of medicines and experimental therapies to address certain psychiatric health disorders and other medical needs including various mental health and addiction disorders”.
As the company stated in a recent press release:
“The shift toward a public health response to the drug crisis will provide greater opportunities for people who use substances to connect with a growing range of harm reduction and treatment options.”
In addition, as the company explained:
“We look forward to a time when Lucy can safely supply harm reduction programs globally, aiming to reduce lethal and or negative consequences associated with adulterated drug supply, particularly considering that fentanyl overdose is the leading cause of deaths among 18 to 45-year-olds in the United States,” said Chris McElvany, the Company’s CEO.
LSDI is “a licensed manufacturer of controlled compounds dedicated to advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies”.
Furthermore, “The Company has licenses to manufacture several controlled substances, including Psilocybin; MDMA; LSD; Psilocin; N,N-DMT; Mescaline; and 2C-B”.
The company’s team “is composed of leading experts from pharmaceutical development, biotechnology, agriculture, applied chemistry, and consumer product manufacturing industries.”
In addition, the company’s “executive team brings deep experience in the development and commercialization of products featuring controlled substances as well as the navigation of regulatory structures applicable to these products”.
LSDI’s target customers “include an increasing number of the leading universities, hospitals and other public, private, and government institutions throughout the world that have launched research programs to conduct clinical studies aimed at understanding the therapeutic potential of a range of psychedelic substances”.
Recently, the company achieved multiple milestones.
On February 13, the company announced:
“Lucy Scientific Discovery Announces Closing of its $7.5 Million Initial Public Offering” In addition, the company announced:
“Lucy Scientific Discovery to Ring Nasdaq Closing Bell Today in Celebration of its IPO”
Here are the company’s comments from this press release:
“We are excited to celebrate this victory at Nasdaq's iconic bell ringing ceremony, as today marks an important milestone for the Company,” said Chris McElvany, the Company’s CEO. “We are pleased to celebrate many months of hard work and team effort that led to the successful completion of our IPO. Seeing Lucy, a pioneer in psychedelics manufacturing, take the next step in its development by becoming the first psychedelics manufacturing company to be listed on NASDAQ is a huge accomplishment. This milestone marks a significant step in the company's growth and plans for expansion. We look forward to the opportunities ahead of us to continue working on improving mental health and finding sustainable solutions for treatment.”
Afterwards, the company announced another big accomplishment:
“Lucy Scientific Discovery Announces First Commercial Sale of Psilocybin Following Initial Delivery of DMT and 5-MeO-DMT to Hadassah BrainLabs”
Here are the company’s comments from this press release:
“This first commercial sale of psilocybin marks a key operational milestone for the company as we shift from pre revenue to revenue producing, and are excited about further opportunities ahead,” said Lucy’s CEO Chris McElvany. “This transaction establishes Lucy’s ability to supply the global psychedelic community with compounds and services. Not only will it strengthen our relationship with the researchers at Hadassah-Hebrew University Medical Center, whose research helps lay the academic foundations indicating the potential of psychedelics, it will lead to the improvement of lives of millions of people around the world.”
Most recently, on Friday, the company announced another significant development:
“Lucy Scientific Teams Up with Pramantha Group to Secure Key Government Contracts and Grants to Enhance its Manufacturing Capabilities”
As the company further explains:
LSDI “partnered with Pramantha Group, a firm specializing in securing key government contracts and grants, to enhance its drug manufacturing capabilities and meet the growing demand for essential drugs and medical supplies”.
Furthermore:
“By leveraging Pramantha Group's expertise in identifying and capturing strategic funding and contract opportunities, Lucy Scientific is well-positioned to compete for and secure key government contracts and grants. With access to these funds, Lucy Scientific will be able to expand its drug manufacturing capabilities and contribute to the country's healthcare needs.”
Here are some of the company’s comments from this press release:
"Our partnership with Pramantha Group will help us navigate the complex landscape of government contracts and grants and identify the right opportunities to support our growth and contribute to the country's healthcare needs," said Lucy Scientific Discovery’s CEO Chris McElvany. "We are excited to work with Pramantha Group to enhance our drug manufacturing capabilities and play a key role in securing the domestic drug supply. Pramantha has a proven track record and a commitment to excellence that makes it an ideal partner for Lucy as we look to grow our operations."
LSDI has multiple potential catalysts favoring a future of increased growth.
The chart appears to be in bounce mode and is flashing oversold with an RSI of 35.34

https://preview.redd.it/sbubqm2juhpa1.png?width=700&format=png&auto=webp&s=378b22df51a5e495591ec91fc56b04478fe99dda
A recent report from Data Bridge Market Research said that the psychedelic drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.3% in the forecast period of 2020 to 2027 and expected to reach USD $6,859.95 million by 2027 from USD 2,077.90 million in 2019. Growing acceptance of psychedelic drugs for treating depression and increasing prevalence of depression and mental disorders are the factors for the market growth. Another report from Research And Markets upped the projection saying that the Psychedelic Drugs Market size is projected to reach USD $10.75 Billion by 2027, from USD 4.75 Bn in 2020 growing at a CAGR of 12.36% during 2021-2027.
It is important to note that approximately 70% of the psychedelics market is attributable to psychedelics manufacturers.
To help with your due diligence, here is a comprehensive report on the psychedelics market from Morgan Stanley.
We will have an updated report on (LSDI) soon,
The Team https://mailchi.mp/broadstreetalerts/lsdi-licensed-manufacturer-supplier-of-psychedelics?e=[UNIQID]
submitted by StocksonHighAlertz to PennyStocksWatch [link] [comments]


2023.03.23 14:48 StocksonHighAlertz NASDAQ $LSDI Licensed Manufacturer & Supplier of Psychedelics

NASDAQ $LSDI Licensed Manufacturer & Supplier of Psychedelics
Hello everyone and welcome to all our new members,
As mentioned yesterday, you're joining us at a great time. Here's why...
We have a recent IPO report on the first psychedelics manufacturing company to be listed on NASDAQ!
Lucy Scientific Discovery Inc. (NASDAQ: LSDI)
Hot sector, building momentum, low float, great setup
Current price $1.39/share as of market close 03/22/23 Public Float 10.15M Shares (Source: Yahoo Finance) Range Since Inception $1.12 - $4.00/share
About Lucy
Lucy Scientific Discovery Inc. is a Nasdaq-listed (NASDAQ: LSDI) licensed producer of compounds for medicinal products. As granted by Health Canada’s Office of Controlled Substances, Lucy maintains a Controlled Drugs and Substances Dealer’s License, under Part J of the Food and Drug Regulations promulgated under the Food and Drugs Act (Canada), or a Dealer’s License. A Dealer’s License authorizes LSDI to develop, sell, deliver, and manufacture (through extraction or synthesis) certain pharmaceutical-grade active pharmaceutical ingredients, or APIs, used in controlled substances and their raw material precursors.
Here is What Lucy Offers (Source: https://www.lucyscientific.com/)
API and Target Formulation Production
By leveraging various scalable production methods, Lucy is uniquely positioned to effectively support current and future market needs at competitive prices.
Lucy's use of efficient and strategic manufacturing practices ensure a consistent and stable supply of the highest quality products from lab- to consumer-scale.
Research, Development and Commercialization Support
We will work directly with researchers and finished product manufacturers in a controlled and collaborative environment to facilitate healthy market growth.
Our team aims to maximize your probability of success while minimizing the time and costs required to achieve your goals.
Lucy (LSDI) has announced multiple breaking developments since its IPO last month.
LSDI is “focused on becoming the premier contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry”.
The company’s mission is to make their “products and research services available for the development of medicines and experimental therapies to address certain psychiatric health disorders and other medical needs including various mental health and addiction disorders”.
As the company stated in a recent press release:
“The shift toward a public health response to the drug crisis will provide greater opportunities for people who use substances to connect with a growing range of harm reduction and treatment options.”
In addition, as the company explained:
“We look forward to a time when Lucy can safely supply harm reduction programs globally, aiming to reduce lethal and or negative consequences associated with adulterated drug supply, particularly considering that fentanyl overdose is the leading cause of deaths among 18 to 45-year-olds in the United States,” said Chris McElvany, the Company’s CEO.
LSDI is “a licensed manufacturer of controlled compounds dedicated to advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies”.
Furthermore, “The Company has licenses to manufacture several controlled substances, including Psilocybin; MDMA; LSD; Psilocin; N,N-DMT; Mescaline; and 2C-B”.
The company’s team “is composed of leading experts from pharmaceutical development, biotechnology, agriculture, applied chemistry, and consumer product manufacturing industries.”
In addition, the company’s “executive team brings deep experience in the development and commercialization of products featuring controlled substances as well as the navigation of regulatory structures applicable to these products”.
LSDI’s target customers “include an increasing number of the leading universities, hospitals and other public, private, and government institutions throughout the world that have launched research programs to conduct clinical studies aimed at understanding the therapeutic potential of a range of psychedelic substances”.
Recently, the company achieved multiple milestones.
On February 13, the company announced:
“Lucy Scientific Discovery Announces Closing of its $7.5 Million Initial Public Offering” In addition, the company announced:
“Lucy Scientific Discovery to Ring Nasdaq Closing Bell Today in Celebration of its IPO”
Here are the company’s comments from this press release:
“We are excited to celebrate this victory at Nasdaq's iconic bell ringing ceremony, as today marks an important milestone for the Company,” said Chris McElvany, the Company’s CEO. “We are pleased to celebrate many months of hard work and team effort that led to the successful completion of our IPO. Seeing Lucy, a pioneer in psychedelics manufacturing, take the next step in its development by becoming the first psychedelics manufacturing company to be listed on NASDAQ is a huge accomplishment. This milestone marks a significant step in the company's growth and plans for expansion. We look forward to the opportunities ahead of us to continue working on improving mental health and finding sustainable solutions for treatment.”
Afterwards, the company announced another big accomplishment:
“Lucy Scientific Discovery Announces First Commercial Sale of Psilocybin Following Initial Delivery of DMT and 5-MeO-DMT to Hadassah BrainLabs”
Here are the company’s comments from this press release:
“This first commercial sale of psilocybin marks a key operational milestone for the company as we shift from pre revenue to revenue producing, and are excited about further opportunities ahead,” said Lucy’s CEO Chris McElvany. “This transaction establishes Lucy’s ability to supply the global psychedelic community with compounds and services. Not only will it strengthen our relationship with the researchers at Hadassah-Hebrew University Medical Center, whose research helps lay the academic foundations indicating the potential of psychedelics, it will lead to the improvement of lives of millions of people around the world.”
Most recently, on Friday, the company announced another significant development:
“Lucy Scientific Teams Up with Pramantha Group to Secure Key Government Contracts and Grants to Enhance its Manufacturing Capabilities”
As the company further explains:
LSDI “partnered with Pramantha Group, a firm specializing in securing key government contracts and grants, to enhance its drug manufacturing capabilities and meet the growing demand for essential drugs and medical supplies”.
Furthermore:
“By leveraging Pramantha Group's expertise in identifying and capturing strategic funding and contract opportunities, Lucy Scientific is well-positioned to compete for and secure key government contracts and grants. With access to these funds, Lucy Scientific will be able to expand its drug manufacturing capabilities and contribute to the country's healthcare needs.”
Here are some of the company’s comments from this press release:
"Our partnership with Pramantha Group will help us navigate the complex landscape of government contracts and grants and identify the right opportunities to support our growth and contribute to the country's healthcare needs," said Lucy Scientific Discovery’s CEO Chris McElvany. "We are excited to work with Pramantha Group to enhance our drug manufacturing capabilities and play a key role in securing the domestic drug supply. Pramantha has a proven track record and a commitment to excellence that makes it an ideal partner for Lucy as we look to grow our operations."
LSDI has multiple potential catalysts favoring a future of increased growth.
The chart appears to be in bounce mode and is flashing oversold with an RSI of 35.34

https://preview.redd.it/pyuik493uhpa1.png?width=700&format=png&auto=webp&s=5ca4b2dd443d79b43e35983787a245ac12513813
A recent report from Data Bridge Market Research said that the psychedelic drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.3% in the forecast period of 2020 to 2027 and expected to reach USD $6,859.95 million by 2027 from USD 2,077.90 million in 2019. Growing acceptance of psychedelic drugs for treating depression and increasing prevalence of depression and mental disorders are the factors for the market growth. Another report from Research And Markets upped the projection saying that the Psychedelic Drugs Market size is projected to reach USD $10.75 Billion by 2027, from USD 4.75 Bn in 2020 growing at a CAGR of 12.36% during 2021-2027.
It is important to note that approximately 70% of the psychedelics market is attributable to psychedelics manufacturers.
To help with your due diligence, here is a comprehensive report on the psychedelics market from Morgan Stanley.
We will have an updated report on (LSDI) soon,
The Team https://mailchi.mp/broadstreetalerts/lsdi-licensed-manufacturer-supplier-of-psychedelics?e=[UNIQID]
submitted by StocksonHighAlertz to 10xPennyStocks [link] [comments]


2023.03.23 14:39 SituationLive4406 $LSDI The first psychedelics manufacturing company to be listed on NASDAQ! Low float, building momentum, Recent IPO, Oversold, Looks Ready

Hello everyone,
Recent IPO report on the first psychedelics manufacturing company to be listed on NASDAQ!
Lucy Scientific Discovery Inc. (NASDAQ: LSDI)
Hot sector, building momentum, low float, great setup
Current price $1.39/share as of market close 03/22/23 Public Float 10.15M Shares (Source: Yahoo Finance) Range Since Inception $1.12 - $4.00/share
About Lucy
Lucy Scientific Discovery Inc. is a Nasdaq-listed (NASDAQ: LSDI) licensed producer of compounds for medicinal products. As granted by Health Canada’s Office of Controlled Substances, Lucy maintains a Controlled Drugs and Substances Dealer’s License, under Part J of the Food and Drug Regulations promulgated under the Food and Drugs Act (Canada), or a Dealer’s License. A Dealer’s License authorizes LSDI to develop, sell, deliver, and manufacture (through extraction or synthesis) certain pharmaceutical-grade active pharmaceutical ingredients, or APIs, used in controlled substances and their raw material precursors.
Here is What Lucy Offers (Source: https://www.lucyscientific.com/)
API and Target Formulation Production
By leveraging various scalable production methods, Lucy is uniquely positioned to effectively support current and future market needs at competitive prices.
Lucy's use of efficient and strategic manufacturing practices ensure a consistent and stable supply of the highest quality products from lab- to consumer-scale.
Research, Development and Commercialization Support
We will work directly with researchers and finished product manufacturers in a controlled and collaborative environment to facilitate healthy market growth.
Our team aims to maximize your probability of success while minimizing the time and costs required to achieve your goals.
Lucy (LSDI) has announced multiple breaking developments since its IPO last month.
LSDI is “focused on becoming the premier contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry”.
The company’s mission is to make their “products and research services available for the development of medicines and experimental therapies to address certain psychiatric health disorders and other medical needs including various mental health and addiction disorders”.
As the company stated in a recent press release:
“The shift toward a public health response to the drug crisis will provide greater opportunities for people who use substances to connect with a growing range of harm reduction and treatment options.”
In addition, as the company explained:
“We look forward to a time when Lucy can safely supply harm reduction programs globally, aiming to reduce lethal and or negative consequences associated with adulterated drug supply, particularly considering that fentanyl overdose is the leading cause of deaths among 18 to 45-year-olds in the United States,” said Chris McElvany, the Company’s CEO.
LSDI is “a licensed manufacturer of controlled compounds dedicated to advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies”.
Furthermore, “The Company has licenses to manufacture several controlled substances, including Psilocybin; MDMA; LSD; Psilocin; N,N-DMT; Mescaline; and 2C-B”.
The company’s team “is composed of leading experts from pharmaceutical development, biotechnology, agriculture, applied chemistry, and consumer product manufacturing industries.”
In addition, the company’s “executive team brings deep experience in the development and commercialization of products featuring controlled substances as well as the navigation of regulatory structures applicable to these products”.
LSDI’s target customers “include an increasing number of the leading universities, hospitals and other public, private, and government institutions throughout the world that have launched research programs to conduct clinical studies aimed at understanding the therapeutic potential of a range of psychedelic substances”.
Recently, the company achieved multiple milestones.
On February 13, the company announced:
“Lucy Scientific Discovery Announces Closing of its $7.5 Million Initial Public Offering” In addition, the company announced:
“Lucy Scientific Discovery to Ring Nasdaq Closing Bell Today in Celebration of its IPO”
Here are the company’s comments from this press release:
“We are excited to celebrate this victory at Nasdaq's iconic bell ringing ceremony, as today marks an important milestone for the Company,” said Chris McElvany, the Company’s CEO. “We are pleased to celebrate many months of hard work and team effort that led to the successful completion of our IPO. Seeing Lucy, a pioneer in psychedelics manufacturing, take the next step in its development by becoming the first psychedelics manufacturing company to be listed on NASDAQ is a huge accomplishment. This milestone marks a significant step in the company's growth and plans for expansion. We look forward to the opportunities ahead of us to continue working on improving mental health and finding sustainable solutions for treatment.”
Afterwards, the company announced another big accomplishment:
“Lucy Scientific Discovery Announces First Commercial Sale of Psilocybin Following Initial Delivery of DMT and 5-MeO-DMT to Hadassah BrainLabs”
Here are the company’s comments from this press release:
“This first commercial sale of psilocybin marks a key operational milestone for the company as we shift from pre revenue to revenue producing, and are excited about further opportunities ahead,” said Lucy’s CEO Chris McElvany. “This transaction establishes Lucy’s ability to supply the global psychedelic community with compounds and services. Not only will it strengthen our relationship with the researchers at Hadassah-Hebrew University Medical Center, whose research helps lay the academic foundations indicating the potential of psychedelics, it will lead to the improvement of lives of millions of people around the world.”
Most recently, on Friday, the company announced another significant development:
“Lucy Scientific Teams Up with Pramantha Group to Secure Key Government Contracts and Grants to Enhance its Manufacturing Capabilities”
As the company further explains:
LSDI “partnered with Pramantha Group, a firm specializing in securing key government contracts and grants, to enhance its drug manufacturing capabilities and meet the growing demand for essential drugs and medical supplies”.
Furthermore:
“By leveraging Pramantha Group's expertise in identifying and capturing strategic funding and contract opportunities, Lucy Scientific is well-positioned to compete for and secure key government contracts and grants. With access to these funds, Lucy Scientific will be able to expand its drug manufacturing capabilities and contribute to the country's healthcare needs.”
Here are some of the company’s comments from this press release:
"Our partnership with Pramantha Group will help us navigate the complex landscape of government contracts and grants and identify the right opportunities to support our growth and contribute to the country's healthcare needs," said Lucy Scientific Discovery’s CEO Chris McElvany. "We are excited to work with Pramantha Group to enhance our drug manufacturing capabilities and play a key role in securing the domestic drug supply. Pramantha has a proven track record and a commitment to excellence that makes it an ideal partner for Lucy as we look to grow our operations."
LSDI has multiple potential catalysts favoring a future of increased growth.
The chart appears to be in bounce mode and is flashing oversold with an RSI of 35.34

https://preview.redd.it/gtzbbqbeshpa1.png?width=700&format=png&auto=webp&s=9fa7a1db4fd209896ba146c55c602ea6129ddc3a
A recent report from Data Bridge Market Research said that the psychedelic drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.3% in the forecast period of 2020 to 2027 and expected to reach USD $6,859.95 million by 2027 from USD 2,077.90 million in 2019. Growing acceptance of psychedelic drugs for treating depression and increasing prevalence of depression and mental disorders are the factors for the market growth. Another report from Research And Markets upped the projection saying that the Psychedelic Drugs Market size is projected to reach USD $10.75 Billion by 2027, from USD 4.75 Bn in 2020 growing at a CAGR of 12.36% during 2021-2027.
It is important to note that approximately 70% of the psychedelics market is attributable to psychedelics manufacturers.
To help with your due diligence, here is a comprehensive report on the psychedelics market from Morgan Stanley.
Disclaimer
submitted by SituationLive4406 to wallstreetbets2 [link] [comments]


2023.03.23 14:38 SituationLive4406 $LSDI The first psychedelics manufacturing company to be listed on NASDAQ! Low float, building momentum, Recent IPO, Oversold, Looks Ready to Run

$LSDI The first psychedelics manufacturing company to be listed on NASDAQ! Low float, building momentum, Recent IPO, Oversold, Looks Ready to Run
Hello everyone,
Great Partnership News with High Times Out Yesterday!
Lucy Scientific Discovery Announces Partnership with High Times® to Develop and Distribute a New Line of Psychoactive Products
‘Mindful by Lucy’
New Line of Psychoactive Products

VANCOUVER, British Columbia, March 23, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific Discovery Inc. (“Lucy” or “The Company”) [NASDAQ:LSDI], a leading NASDAQ-listed psychedelic drug manufacturer, announced today the launch of a new line of unscheduled psychoactive compounds that will be available for sale throughout the United States, and where permitted throughout the rest of the world.
The first line in the new family of brands contains Amanita Muscaria mushrooms, a psychoactive adaptogen. The product leverages the compounds of these mushrooms, and a proprietary blend of other natural functional ingredients, to create a transformative experience for consumers worldwide. This product line is named ‘Mindful by Lucy’.
Lucy Scientific will produce Mindful with High Times, through a strategic partnership with Hightimes Holding Corp., the parent company of High Times®, the most well-known brand in cannabis. This collaboration aims to distribute and market the products initially through High Times' websites and social channels which reach over 10 million people across their owned and operated properties and social media accounts.
With a product launch targeted for Q2 2023, this new line is well-positioned to capitalize on the growing market for psychoactive alternatives, which Forbes predicts will double to over $5 billion in gross sales by 2025.
Lucy and High Times entered into a strategic investment agreement in January whereby Lucy received $2.5 million in advertising credits that will help launch the new brand into market through High Times channels and experiential events.
Chris McElvany, Chief Executive Officer of Lucy Scientific Discovery Inc., stated, “As awareness and acceptance of alternative treatments for various conditions, such as PTSD, anxiety disorders, and depression, continue to grow, adaptogens are emerging as a leading therapeutic remedy. This partnership between Lucy and High Times will enable the two companies to expand the reach of Lucy’s products and promote the potential health benefits to a broader audience.” FULL ARTICLE

Recent IPO report on the first psychedelics manufacturing company to be listed on NASDAQ!
Lucy Scientific Discovery Inc. (NASDAQ: LSDI)
Hot sector, building momentum, low float, great setup
Current price $1.39/share as of market close 03/22/23 Public Float 10.15M Shares (Source: Yahoo Finance)Range Since Inception $1.12 - $4.00/share
About Lucy
Lucy Scientific Discovery Inc. is a Nasdaq-listed (NASDAQ: LSDI) licensed producer of compounds for medicinal products. As granted by Health Canada’s Office of Controlled Substances, Lucy maintains a Controlled Drugs and Substances Dealer’s License, under Part J of the Food and Drug Regulations promulgated under the Food and Drugs Act (Canada), or a Dealer’s License. A Dealer’s License authorizes LSDI to develop, sell, deliver, and manufacture (through extraction or synthesis) certain pharmaceutical-grade active pharmaceutical ingredients, or APIs, used in controlled substances and their raw material precursors.
Here is What Lucy Offers (Source: https://www.lucyscientific.com/)
API and Target Formulation Production
By leveraging various scalable production methods, Lucy is uniquely positioned to effectively support current and future market needs at competitive prices.
Lucy's use of efficient and strategic manufacturing practices ensure a consistent and stable supply of the highest quality products from lab- to consumer-scale.
Research, Development and Commercialization Support
We will work directly with researchers and finished product manufacturers in a controlled and collaborative environment to facilitate healthy market growth.
Our team aims to maximize your probability of success while minimizing the time and costs required to achieve your goals.
Lucy (LSDI) has announced multiple breaking developments since its IPO last month.
LSDI is “focused on becoming the premier contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry”.
The company’s mission is to make their “products and research services available for the development of medicines and experimental therapies to address certain psychiatric health disorders and other medical needs including various mental health and addiction disorders”.
As the company stated in a recent press release:
“The shift toward a public health response to the drug crisis will provide greater opportunities for people who use substances to connect with a growing range of harm reduction and treatment options.”
In addition, as the company explained:
“We look forward to a time when Lucy can safely supply harm reduction programs globally, aiming to reduce lethal and or negative consequences associated with adulterated drug supply, particularly considering that fentanyl overdose is the leading cause of deaths among 18 to 45-year-olds in the United States,” said Chris McElvany, the Company’s CEO.
LSDI is “a licensed manufacturer of controlled compounds dedicated to advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies”.
Furthermore, “The Company has licenses to manufacture several controlled substances, including Psilocybin; MDMA; LSD; Psilocin; N,N-DMT; Mescaline; and 2C-B”.
The company’s team “is composed of leading experts from pharmaceutical development, biotechnology, agriculture, applied chemistry, and consumer product manufacturing industries.”
In addition, the company’s “executive team brings deep experience in the development and commercialization of products featuring controlled substances as well as the navigation of regulatory structures applicable to these products”.
LSDI’s target customers “include an increasing number of the leading universities, hospitals and other public, private, and government institutions throughout the world that have launched research programs to conduct clinical studies aimed at understanding the therapeutic potential of a range of psychedelic substances”.
Recently, the company achieved multiple milestones.
On February 13, the company announced:
“Lucy Scientific Discovery Announces Closing of its $7.5 Million Initial Public Offering”In addition, the company announced:
“Lucy Scientific Discovery to Ring Nasdaq Closing Bell Today in Celebration of its IPO”
Here are the company’s comments from this press release:
“We are excited to celebrate this victory at Nasdaq's iconic bell ringing ceremony, as today marks an important milestone for the Company,” said Chris McElvany, the Company’s CEO. “We are pleased to celebrate many months of hard work and team effort that led to the successful completion of our IPO. Seeing Lucy, a pioneer in psychedelics manufacturing, take the next step in its development by becoming the first psychedelics manufacturing company to be listed on NASDAQ is a huge accomplishment. This milestone marks a significant step in the company's growth and plans for expansion. We look forward to the opportunities ahead of us to continue working on improving mental health and finding sustainable solutions for treatment.”
Afterwards, the company announced another big accomplishment:
“Lucy Scientific Discovery Announces First Commercial Sale of Psilocybin Following Initial Delivery of DMT and 5-MeO-DMT to Hadassah BrainLabs”
Here are the company’s comments from this press release:
“This first commercial sale of psilocybin marks a key operational milestone for the company as we shift from pre revenue to revenue producing, and are excited about further opportunities ahead,” said Lucy’s CEO Chris McElvany. “This transaction establishes Lucy’s ability to supply the global psychedelic community with compounds and services. Not only will it strengthen our relationship with the researchers at Hadassah-Hebrew University Medical Center, whose research helps lay the academic foundations indicating the potential of psychedelics, it will lead to the improvement of lives of millions of people around the world.”
Most recently, on Friday, the company announced another significant development:
“Lucy Scientific Teams Up with Pramantha Group to Secure Key Government Contracts and Grants to Enhance its Manufacturing Capabilities”
As the company further explains:
LSDI “partnered with Pramantha Group, a firm specializing in securing key government contracts and grants, to enhance its drug manufacturing capabilities and meet the growing demand for essential drugs and medical supplies”.
Furthermore:
“By leveraging Pramantha Group's expertise in identifying and capturing strategic funding and contract opportunities, Lucy Scientific is well-positioned to compete for and secure key government contracts and grants. With access to these funds, Lucy Scientific will be able to expand its drug manufacturing capabilities and contribute to the country's healthcare needs.”
Here are some of the company’s comments from this press release:
"Our partnership with Pramantha Group will help us navigate the complex landscape of government contracts and grants and identify the right opportunities to support our growth and contribute to the country's healthcare needs," said Lucy Scientific Discovery’s CEO Chris McElvany. "We are excited to work with Pramantha Group to enhance our drug manufacturing capabilities and play a key role in securing the domestic drug supply. Pramantha has a proven track record and a commitment to excellence that makes it an ideal partner for Lucy as we look to grow our operations."
LSDI has multiple potential catalysts favoring a future of increased growth.
The chart appears to be in bounce mode and is flashing oversold with an RSI of 35.34

https://preview.redd.it/b678w2prrhpa1.png?width=700&format=png&auto=webp&s=647a3588a84742645e1952faa2edf4e7f636c5b0
A recent report from Data Bridge Market Research said that the psychedelic drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.3% in the forecast period of 2020 to 2027 and expected to reach USD $6,859.95 million by 2027 from USD 2,077.90 million in 2019. Growing acceptance of psychedelic drugs for treating depression and increasing prevalence of depression and mental disorders are the factors for the market growth. Another report from Research And Markets upped the projection saying that the Psychedelic Drugs Market size is projected to reach USD $10.75 Billion by 2027, from USD 4.75 Bn in 2020 growing at a CAGR of 12.36% during 2021-2027.
It is important to note that approximately 70% of the psychedelics market is attributable to psychedelics manufacturers.
To help with your due diligence, here is a comprehensive report on the psychedelics market from Morgan Stanley.
Disclaimer
submitted by SituationLive4406 to Wallstreetbetsnew [link] [comments]


2023.03.23 14:33 SituationLive4406 $LSDI The first psychedelics manufacturing company to be listed on NASDAQ! Low float, building momentum, Recent IPO, Oversold, Looks Ready to Run

$LSDI The first psychedelics manufacturing company to be listed on NASDAQ! Low float, building momentum, Recent IPO, Oversold, Looks Ready to Run
Hello everyone,
Recent IPO report on the first psychedelics manufacturing company to be listed on NASDAQ!
Lucy Scientific Discovery Inc. (NASDAQ: LSDI)
Hot sector, building momentum, low float, great setup
Current price $1.39/share as of market close 03/22/23 Public Float 10.15M Shares (Source: Yahoo Finance) Range Since Inception $1.12 - $4.00/share
About Lucy
Lucy Scientific Discovery Inc. is a Nasdaq-listed (NASDAQ: LSDI) licensed producer of compounds for medicinal products. As granted by Health Canada’s Office of Controlled Substances, Lucy maintains a Controlled Drugs and Substances Dealer’s License, under Part J of the Food and Drug Regulations promulgated under the Food and Drugs Act (Canada), or a Dealer’s License. A Dealer’s License authorizes LSDI to develop, sell, deliver, and manufacture (through extraction or synthesis) certain pharmaceutical-grade active pharmaceutical ingredients, or APIs, used in controlled substances and their raw material precursors.
Here is What Lucy Offers (Source: https://www.lucyscientific.com/)
API and Target Formulation Production
By leveraging various scalable production methods, Lucy is uniquely positioned to effectively support current and future market needs at competitive prices.
Lucy's use of efficient and strategic manufacturing practices ensure a consistent and stable supply of the highest quality products from lab- to consumer-scale.
Research, Development and Commercialization Support
We will work directly with researchers and finished product manufacturers in a controlled and collaborative environment to facilitate healthy market growth.
Our team aims to maximize your probability of success while minimizing the time and costs required to achieve your goals.
Lucy (LSDI) has announced multiple breaking developments since its IPO last month.
LSDI is “focused on becoming the premier contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry”.
The company’s mission is to make their “products and research services available for the development of medicines and experimental therapies to address certain psychiatric health disorders and other medical needs including various mental health and addiction disorders”.
As the company stated in a recent press release:
“The shift toward a public health response to the drug crisis will provide greater opportunities for people who use substances to connect with a growing range of harm reduction and treatment options.”
In addition, as the company explained:
“We look forward to a time when Lucy can safely supply harm reduction programs globally, aiming to reduce lethal and or negative consequences associated with adulterated drug supply, particularly considering that fentanyl overdose is the leading cause of deaths among 18 to 45-year-olds in the United States,” said Chris McElvany, the Company’s CEO.
LSDI is “a licensed manufacturer of controlled compounds dedicated to advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies”.
Furthermore, “The Company has licenses to manufacture several controlled substances, including Psilocybin; MDMA; LSD; Psilocin; N,N-DMT; Mescaline; and 2C-B”.
The company’s team “is composed of leading experts from pharmaceutical development, biotechnology, agriculture, applied chemistry, and consumer product manufacturing industries.”
In addition, the company’s “executive team brings deep experience in the development and commercialization of products featuring controlled substances as well as the navigation of regulatory structures applicable to these products”.
LSDI’s target customers “include an increasing number of the leading universities, hospitals and other public, private, and government institutions throughout the world that have launched research programs to conduct clinical studies aimed at understanding the therapeutic potential of a range of psychedelic substances”.
Recently, the company achieved multiple milestones.
On February 13, the company announced:
“Lucy Scientific Discovery Announces Closing of its $7.5 Million Initial Public Offering” In addition, the company announced:
“Lucy Scientific Discovery to Ring Nasdaq Closing Bell Today in Celebration of its IPO”
Here are the company’s comments from this press release:
“We are excited to celebrate this victory at Nasdaq's iconic bell ringing ceremony, as today marks an important milestone for the Company,” said Chris McElvany, the Company’s CEO. “We are pleased to celebrate many months of hard work and team effort that led to the successful completion of our IPO. Seeing Lucy, a pioneer in psychedelics manufacturing, take the next step in its development by becoming the first psychedelics manufacturing company to be listed on NASDAQ is a huge accomplishment. This milestone marks a significant step in the company's growth and plans for expansion. We look forward to the opportunities ahead of us to continue working on improving mental health and finding sustainable solutions for treatment.”
Afterwards, the company announced another big accomplishment:
“Lucy Scientific Discovery Announces First Commercial Sale of Psilocybin Following Initial Delivery of DMT and 5-MeO-DMT to Hadassah BrainLabs”
Here are the company’s comments from this press release:
“This first commercial sale of psilocybin marks a key operational milestone for the company as we shift from pre revenue to revenue producing, and are excited about further opportunities ahead,” said Lucy’s CEO Chris McElvany. “This transaction establishes Lucy’s ability to supply the global psychedelic community with compounds and services. Not only will it strengthen our relationship with the researchers at Hadassah-Hebrew University Medical Center, whose research helps lay the academic foundations indicating the potential of psychedelics, it will lead to the improvement of lives of millions of people around the world.”
Most recently, on Friday, the company announced another significant development:
“Lucy Scientific Teams Up with Pramantha Group to Secure Key Government Contracts and Grants to Enhance its Manufacturing Capabilities”
As the company further explains:
LSDI “partnered with Pramantha Group, a firm specializing in securing key government contracts and grants, to enhance its drug manufacturing capabilities and meet the growing demand for essential drugs and medical supplies”.
Furthermore:
“By leveraging Pramantha Group's expertise in identifying and capturing strategic funding and contract opportunities, Lucy Scientific is well-positioned to compete for and secure key government contracts and grants. With access to these funds, Lucy Scientific will be able to expand its drug manufacturing capabilities and contribute to the country's healthcare needs.”
Here are some of the company’s comments from this press release:
"Our partnership with Pramantha Group will help us navigate the complex landscape of government contracts and grants and identify the right opportunities to support our growth and contribute to the country's healthcare needs," said Lucy Scientific Discovery’s CEO Chris McElvany. "We are excited to work with Pramantha Group to enhance our drug manufacturing capabilities and play a key role in securing the domestic drug supply. Pramantha has a proven track record and a commitment to excellence that makes it an ideal partner for Lucy as we look to grow our operations."
LSDI has multiple potential catalysts favoring a future of increased growth.
The chart appears to be in bounce mode and is flashing oversold with an RSI of 35.34

https://preview.redd.it/gmq4z4ggrhpa1.png?width=700&format=png&auto=webp&s=6ec04d14294d7bd9c2f6bc0f3bd980527f55258a
A recent report from Data Bridge Market Research said that the psychedelic drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.3% in the forecast period of 2020 to 2027 and expected to reach USD $6,859.95 million by 2027 from USD 2,077.90 million in 2019. Growing acceptance of psychedelic drugs for treating depression and increasing prevalence of depression and mental disorders are the factors for the market growth. Another report from Research And Markets upped the projection saying that the Psychedelic Drugs Market size is projected to reach USD $10.75 Billion by 2027, from USD 4.75 Bn in 2020 growing at a CAGR of 12.36% during 2021-2027.
It is important to note that approximately 70% of the psychedelics market is attributable to psychedelics manufacturers.
To help with your due diligence, here is a comprehensive report on the psychedelics market from Morgan Stanley.
Disclaimer
submitted by SituationLive4406 to biotech_stocks [link] [comments]


2023.03.23 14:20 SituationLive4406 $LSDI The first psychedelics manufacturing company to be listed on NASDAQ! Low float, building momentum, Recent IPO, Oversold, Looks Ready to Run

$LSDI The first psychedelics manufacturing company to be listed on NASDAQ! Low float, building momentum, Recent IPO, Oversold, Looks Ready to Run
Hello everyone,
Recent IPO report on the first psychedelics manufacturing company to be listed on NASDAQ!
Lucy Scientific Discovery Inc. (NASDAQ: LSDI)
Hot sector, building momentum, low float, great setup
Current price $1.39/share as of market close 03/22/23 Public Float 10.15M Shares (Source: Yahoo Finance) Range Since Inception $1.12 - $4.00/share
About Lucy
Lucy Scientific Discovery Inc. is a Nasdaq-listed (NASDAQ: LSDI) licensed producer of compounds for medicinal products. As granted by Health Canada’s Office of Controlled Substances, Lucy maintains a Controlled Drugs and Substances Dealer’s License, under Part J of the Food and Drug Regulations promulgated under the Food and Drugs Act (Canada), or a Dealer’s License. A Dealer’s License authorizes LSDI to develop, sell, deliver, and manufacture (through extraction or synthesis) certain pharmaceutical-grade active pharmaceutical ingredients, or APIs, used in controlled substances and their raw material precursors.
Here is What Lucy Offers (Source: https://www.lucyscientific.com/)
API and Target Formulation Production
By leveraging various scalable production methods, Lucy is uniquely positioned to effectively support current and future market needs at competitive prices.
Lucy's use of efficient and strategic manufacturing practices ensure a consistent and stable supply of the highest quality products from lab- to consumer-scale.
Research, Development and Commercialization Support
We will work directly with researchers and finished product manufacturers in a controlled and collaborative environment to facilitate healthy market growth.
Our team aims to maximize your probability of success while minimizing the time and costs required to achieve your goals.
Lucy (LSDI) has announced multiple breaking developments since its IPO last month.
LSDI is “focused on becoming the premier contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry”.
The company’s mission is to make their “products and research services available for the development of medicines and experimental therapies to address certain psychiatric health disorders and other medical needs including various mental health and addiction disorders”.
As the company stated in a recent press release:
“The shift toward a public health response to the drug crisis will provide greater opportunities for people who use substances to connect with a growing range of harm reduction and treatment options.”
In addition, as the company explained:
“We look forward to a time when Lucy can safely supply harm reduction programs globally, aiming to reduce lethal and or negative consequences associated with adulterated drug supply, particularly considering that fentanyl overdose is the leading cause of deaths among 18 to 45-year-olds in the United States,” said Chris McElvany, the Company’s CEO.
LSDI is “a licensed manufacturer of controlled compounds dedicated to advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies”.
Furthermore, “The Company has licenses to manufacture several controlled substances, including Psilocybin; MDMA; LSD; Psilocin; N,N-DMT; Mescaline; and 2C-B”.
The company’s team “is composed of leading experts from pharmaceutical development, biotechnology, agriculture, applied chemistry, and consumer product manufacturing industries.”
In addition, the company’s “executive team brings deep experience in the development and commercialization of products featuring controlled substances as well as the navigation of regulatory structures applicable to these products”.
LSDI’s target customers “include an increasing number of the leading universities, hospitals and other public, private, and government institutions throughout the world that have launched research programs to conduct clinical studies aimed at understanding the therapeutic potential of a range of psychedelic substances”.
Recently, the company achieved multiple milestones.
On February 13, the company announced:
“Lucy Scientific Discovery Announces Closing of its $7.5 Million Initial Public Offering” In addition, the company announced:
“Lucy Scientific Discovery to Ring Nasdaq Closing Bell Today in Celebration of its IPO”
Here are the company’s comments from this press release:
“We are excited to celebrate this victory at Nasdaq's iconic bell ringing ceremony, as today marks an important milestone for the Company,” said Chris McElvany, the Company’s CEO. “We are pleased to celebrate many months of hard work and team effort that led to the successful completion of our IPO. Seeing Lucy, a pioneer in psychedelics manufacturing, take the next step in its development by becoming the first psychedelics manufacturing company to be listed on NASDAQ is a huge accomplishment. This milestone marks a significant step in the company's growth and plans for expansion. We look forward to the opportunities ahead of us to continue working on improving mental health and finding sustainable solutions for treatment.”
Afterwards, the company announced another big accomplishment:
“Lucy Scientific Discovery Announces First Commercial Sale of Psilocybin Following Initial Delivery of DMT and 5-MeO-DMT to Hadassah BrainLabs”
Here are the company’s comments from this press release:
“This first commercial sale of psilocybin marks a key operational milestone for the company as we shift from pre revenue to revenue producing, and are excited about further opportunities ahead,” said Lucy’s CEO Chris McElvany. “This transaction establishes Lucy’s ability to supply the global psychedelic community with compounds and services. Not only will it strengthen our relationship with the researchers at Hadassah-Hebrew University Medical Center, whose research helps lay the academic foundations indicating the potential of psychedelics, it will lead to the improvement of lives of millions of people around the world.”
Most recently, on Friday, the company announced another significant development:
“Lucy Scientific Teams Up with Pramantha Group to Secure Key Government Contracts and Grants to Enhance its Manufacturing Capabilities”
As the company further explains:
LSDI “partnered with Pramantha Group, a firm specializing in securing key government contracts and grants, to enhance its drug manufacturing capabilities and meet the growing demand for essential drugs and medical supplies”.
Furthermore:
“By leveraging Pramantha Group's expertise in identifying and capturing strategic funding and contract opportunities, Lucy Scientific is well-positioned to compete for and secure key government contracts and grants. With access to these funds, Lucy Scientific will be able to expand its drug manufacturing capabilities and contribute to the country's healthcare needs.”
Here are some of the company’s comments from this press release:
"Our partnership with Pramantha Group will help us navigate the complex landscape of government contracts and grants and identify the right opportunities to support our growth and contribute to the country's healthcare needs," said Lucy Scientific Discovery’s CEO Chris McElvany. "We are excited to work with Pramantha Group to enhance our drug manufacturing capabilities and play a key role in securing the domestic drug supply. Pramantha has a proven track record and a commitment to excellence that makes it an ideal partner for Lucy as we look to grow our operations."
LSDI has multiple potential catalysts favoring a future of increased growth.
The chart appears to be in bounce mode and is flashing oversold with an RSI of 35.34

https://preview.redd.it/umk5rkd3phpa1.png?width=700&format=png&auto=webp&s=0b8d4d15013ee3e037d998fd9fa4bdf79f282781
A recent report from Data Bridge Market Research said that the psychedelic drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.3% in the forecast period of 2020 to 2027 and expected to reach USD $6,859.95 million by 2027 from USD 2,077.90 million in 2019. Growing acceptance of psychedelic drugs for treating depression and increasing prevalence of depression and mental disorders are the factors for the market growth. Another report from Research And Markets upped the projection saying that the Psychedelic Drugs Market size is projected to reach USD $10.75 Billion by 2027, from USD 4.75 Bn in 2020 growing at a CAGR of 12.36% during 2021-2027.
It is important to note that approximately 70% of the psychedelics market is attributable to psychedelics manufacturers.
To help with your due diligence, here is a comprehensive report on the psychedelics market from Morgan Stanley.
Disclaimer
submitted by SituationLive4406 to SmallCapGrowth [link] [comments]


2023.03.23 14:19 SituationLive4406 $LSDI The first psychedelics manufacturing company to be listed on NASDAQ! Low float, building momentum, Recent IPO, Oversold, Looks Ready to Run

$LSDI The first psychedelics manufacturing company to be listed on NASDAQ! Low float, building momentum, Recent IPO, Oversold, Looks Ready to Run
Hello everyone,
Recent IPO report on the first psychedelics manufacturing company to be listed on NASDAQ!
Lucy Scientific Discovery Inc. (NASDAQ: LSDI)
Hot sector, building momentum, low float, great setup
Current price $1.39/share as of market close 03/22/23 Public Float 10.15M Shares (Source: Yahoo Finance) Range Since Inception $1.12 - $4.00/share
About Lucy
Lucy Scientific Discovery Inc. is a Nasdaq-listed (NASDAQ: LSDI) licensed producer of compounds for medicinal products. As granted by Health Canada’s Office of Controlled Substances, Lucy maintains a Controlled Drugs and Substances Dealer’s License, under Part J of the Food and Drug Regulations promulgated under the Food and Drugs Act (Canada), or a Dealer’s License. A Dealer’s License authorizes LSDI to develop, sell, deliver, and manufacture (through extraction or synthesis) certain pharmaceutical-grade active pharmaceutical ingredients, or APIs, used in controlled substances and their raw material precursors.
Here is What Lucy Offers (Source: https://www.lucyscientific.com/)
API and Target Formulation Production
By leveraging various scalable production methods, Lucy is uniquely positioned to effectively support current and future market needs at competitive prices.
Lucy's use of efficient and strategic manufacturing practices ensure a consistent and stable supply of the highest quality products from lab- to consumer-scale.
Research, Development and Commercialization Support
We will work directly with researchers and finished product manufacturers in a controlled and collaborative environment to facilitate healthy market growth.
Our team aims to maximize your probability of success while minimizing the time and costs required to achieve your goals.
Lucy (LSDI) has announced multiple breaking developments since its IPO last month.
LSDI is “focused on becoming the premier contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry”.
The company’s mission is to make their “products and research services available for the development of medicines and experimental therapies to address certain psychiatric health disorders and other medical needs including various mental health and addiction disorders”.
As the company stated in a recent press release:
“The shift toward a public health response to the drug crisis will provide greater opportunities for people who use substances to connect with a growing range of harm reduction and treatment options.”
In addition, as the company explained:
“We look forward to a time when Lucy can safely supply harm reduction programs globally, aiming to reduce lethal and or negative consequences associated with adulterated drug supply, particularly considering that fentanyl overdose is the leading cause of deaths among 18 to 45-year-olds in the United States,” said Chris McElvany, the Company’s CEO.
LSDI is “a licensed manufacturer of controlled compounds dedicated to advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies”.
Furthermore, “The Company has licenses to manufacture several controlled substances, including Psilocybin; MDMA; LSD; Psilocin; N,N-DMT; Mescaline; and 2C-B”.
The company’s team “is composed of leading experts from pharmaceutical development, biotechnology, agriculture, applied chemistry, and consumer product manufacturing industries.”
In addition, the company’s “executive team brings deep experience in the development and commercialization of products featuring controlled substances as well as the navigation of regulatory structures applicable to these products”.
LSDI’s target customers “include an increasing number of the leading universities, hospitals and other public, private, and government institutions throughout the world that have launched research programs to conduct clinical studies aimed at understanding the therapeutic potential of a range of psychedelic substances”.
Recently, the company achieved multiple milestones.
On February 13, the company announced:
“Lucy Scientific Discovery Announces Closing of its $7.5 Million Initial Public Offering” In addition, the company announced:
“Lucy Scientific Discovery to Ring Nasdaq Closing Bell Today in Celebration of its IPO”
Here are the company’s comments from this press release:
“We are excited to celebrate this victory at Nasdaq's iconic bell ringing ceremony, as today marks an important milestone for the Company,” said Chris McElvany, the Company’s CEO. “We are pleased to celebrate many months of hard work and team effort that led to the successful completion of our IPO. Seeing Lucy, a pioneer in psychedelics manufacturing, take the next step in its development by becoming the first psychedelics manufacturing company to be listed on NASDAQ is a huge accomplishment. This milestone marks a significant step in the company's growth and plans for expansion. We look forward to the opportunities ahead of us to continue working on improving mental health and finding sustainable solutions for treatment.”
Afterwards, the company announced another big accomplishment:
“Lucy Scientific Discovery Announces First Commercial Sale of Psilocybin Following Initial Delivery of DMT and 5-MeO-DMT to Hadassah BrainLabs”
Here are the company’s comments from this press release:
“This first commercial sale of psilocybin marks a key operational milestone for the company as we shift from pre revenue to revenue producing, and are excited about further opportunities ahead,” said Lucy’s CEO Chris McElvany. “This transaction establishes Lucy’s ability to supply the global psychedelic community with compounds and services. Not only will it strengthen our relationship with the researchers at Hadassah-Hebrew University Medical Center, whose research helps lay the academic foundations indicating the potential of psychedelics, it will lead to the improvement of lives of millions of people around the world.”
Most recently, on Friday, the company announced another significant development:
“Lucy Scientific Teams Up with Pramantha Group to Secure Key Government Contracts and Grants to Enhance its Manufacturing Capabilities”
As the company further explains:
LSDI “partnered with Pramantha Group, a firm specializing in securing key government contracts and grants, to enhance its drug manufacturing capabilities and meet the growing demand for essential drugs and medical supplies”.
Furthermore:
“By leveraging Pramantha Group's expertise in identifying and capturing strategic funding and contract opportunities, Lucy Scientific is well-positioned to compete for and secure key government contracts and grants. With access to these funds, Lucy Scientific will be able to expand its drug manufacturing capabilities and contribute to the country's healthcare needs.”
Here are some of the company’s comments from this press release:
"Our partnership with Pramantha Group will help us navigate the complex landscape of government contracts and grants and identify the right opportunities to support our growth and contribute to the country's healthcare needs," said Lucy Scientific Discovery’s CEO Chris McElvany. "We are excited to work with Pramantha Group to enhance our drug manufacturing capabilities and play a key role in securing the domestic drug supply. Pramantha has a proven track record and a commitment to excellence that makes it an ideal partner for Lucy as we look to grow our operations."
LSDI has multiple potential catalysts favoring a future of increased growth.
The chart appears to be in bounce mode and is flashing oversold with an RSI of 35.34


https://preview.redd.it/jntsu3jyohpa1.png?width=700&format=png&auto=webp&s=1818a2acff8444f46eeee543a5f1c776899cc7c3
A recent report from Data Bridge Market Research said that the psychedelic drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.3% in the forecast period of 2020 to 2027 and expected to reach USD $6,859.95 million by 2027 from USD 2,077.90 million in 2019. Growing acceptance of psychedelic drugs for treating depression and increasing prevalence of depression and mental disorders are the factors for the market growth. Another report from Research And Markets upped the projection saying that the Psychedelic Drugs Market size is projected to reach USD $10.75 Billion by 2027, from USD 4.75 Bn in 2020 growing at a CAGR of 12.36% during 2021-2027.
It is important to note that approximately 70% of the psychedelics market is attributable to psychedelics manufacturers.
To help with your due diligence, here is a comprehensive report on the psychedelics market from Morgan Stanley.
Disclaimer
submitted by SituationLive4406 to BreakoutStocks [link] [comments]


2023.03.23 14:18 SituationLive4406 $LSDI The first psychedelics manufacturing company to be listed on NASDAQ! Low float, building momentum, Recent IPO, Oversold, Looks Ready to Run

$LSDI The first psychedelics manufacturing company to be listed on NASDAQ! Low float, building momentum, Recent IPO, Oversold, Looks Ready to Run
Hello everyone,
Recent IPO report on the first psychedelics manufacturing company to be listed on NASDAQ!
Lucy Scientific Discovery Inc. (NASDAQ: LSDI)
Hot sector, building momentum, low float, great setup
Current price $1.39/share as of market close 03/22/23 Public Float 10.15M Shares (Source: Yahoo Finance) Range Since Inception $1.12 - $4.00/share
About Lucy
Lucy Scientific Discovery Inc. is a Nasdaq-listed (NASDAQ: LSDI) licensed producer of compounds for medicinal products. As granted by Health Canada’s Office of Controlled Substances, Lucy maintains a Controlled Drugs and Substances Dealer’s License, under Part J of the Food and Drug Regulations promulgated under the Food and Drugs Act (Canada), or a Dealer’s License. A Dealer’s License authorizes LSDI to develop, sell, deliver, and manufacture (through extraction or synthesis) certain pharmaceutical-grade active pharmaceutical ingredients, or APIs, used in controlled substances and their raw material precursors.
Here is What Lucy Offers (Source: https://www.lucyscientific.com/)
API and Target Formulation Production
By leveraging various scalable production methods, Lucy is uniquely positioned to effectively support current and future market needs at competitive prices.
Lucy's use of efficient and strategic manufacturing practices ensure a consistent and stable supply of the highest quality products from lab- to consumer-scale.
Research, Development and Commercialization Support
We will work directly with researchers and finished product manufacturers in a controlled and collaborative environment to facilitate healthy market growth.
Our team aims to maximize your probability of success while minimizing the time and costs required to achieve your goals.
Lucy (LSDI) has announced multiple breaking developments since its IPO last month.
LSDI is “focused on becoming the premier contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry”.
The company’s mission is to make their “products and research services available for the development of medicines and experimental therapies to address certain psychiatric health disorders and other medical needs including various mental health and addiction disorders”.
As the company stated in a recent press release:
“The shift toward a public health response to the drug crisis will provide greater opportunities for people who use substances to connect with a growing range of harm reduction and treatment options.”
In addition, as the company explained:
“We look forward to a time when Lucy can safely supply harm reduction programs globally, aiming to reduce lethal and or negative consequences associated with adulterated drug supply, particularly considering that fentanyl overdose is the leading cause of deaths among 18 to 45-year-olds in the United States,” said Chris McElvany, the Company’s CEO.
LSDI is “a licensed manufacturer of controlled compounds dedicated to advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies”.
Furthermore, “The Company has licenses to manufacture several controlled substances, including Psilocybin; MDMA; LSD; Psilocin; N,N-DMT; Mescaline; and 2C-B”.
The company’s team “is composed of leading experts from pharmaceutical development, biotechnology, agriculture, applied chemistry, and consumer product manufacturing industries.”
In addition, the company’s “executive team brings deep experience in the development and commercialization of products featuring controlled substances as well as the navigation of regulatory structures applicable to these products”.
LSDI’s target customers “include an increasing number of the leading universities, hospitals and other public, private, and government institutions throughout the world that have launched research programs to conduct clinical studies aimed at understanding the therapeutic potential of a range of psychedelic substances”.
Recently, the company achieved multiple milestones.
On February 13, the company announced:
“Lucy Scientific Discovery Announces Closing of its $7.5 Million Initial Public Offering” In addition, the company announced:
“Lucy Scientific Discovery to Ring Nasdaq Closing Bell Today in Celebration of its IPO”
Here are the company’s comments from this press release:
“We are excited to celebrate this victory at Nasdaq's iconic bell ringing ceremony, as today marks an important milestone for the Company,” said Chris McElvany, the Company’s CEO. “We are pleased to celebrate many months of hard work and team effort that led to the successful completion of our IPO. Seeing Lucy, a pioneer in psychedelics manufacturing, take the next step in its development by becoming the first psychedelics manufacturing company to be listed on NASDAQ is a huge accomplishment. This milestone marks a significant step in the company's growth and plans for expansion. We look forward to the opportunities ahead of us to continue working on improving mental health and finding sustainable solutions for treatment.”
Afterwards, the company announced another big accomplishment:
“Lucy Scientific Discovery Announces First Commercial Sale of Psilocybin Following Initial Delivery of DMT and 5-MeO-DMT to Hadassah BrainLabs”
Here are the company’s comments from this press release:
“This first commercial sale of psilocybin marks a key operational milestone for the company as we shift from pre revenue to revenue producing, and are excited about further opportunities ahead,” said Lucy’s CEO Chris McElvany. “This transaction establishes Lucy’s ability to supply the global psychedelic community with compounds and services. Not only will it strengthen our relationship with the researchers at Hadassah-Hebrew University Medical Center, whose research helps lay the academic foundations indicating the potential of psychedelics, it will lead to the improvement of lives of millions of people around the world.”
Most recently, on Friday, the company announced another significant development:
“Lucy Scientific Teams Up with Pramantha Group to Secure Key Government Contracts and Grants to Enhance its Manufacturing Capabilities”
As the company further explains:
LSDI “partnered with Pramantha Group, a firm specializing in securing key government contracts and grants, to enhance its drug manufacturing capabilities and meet the growing demand for essential drugs and medical supplies”.
Furthermore:
“By leveraging Pramantha Group's expertise in identifying and capturing strategic funding and contract opportunities, Lucy Scientific is well-positioned to compete for and secure key government contracts and grants. With access to these funds, Lucy Scientific will be able to expand its drug manufacturing capabilities and contribute to the country's healthcare needs.”
Here are some of the company’s comments from this press release:
"Our partnership with Pramantha Group will help us navigate the complex landscape of government contracts and grants and identify the right opportunities to support our growth and contribute to the country's healthcare needs," said Lucy Scientific Discovery’s CEO Chris McElvany. "We are excited to work with Pramantha Group to enhance our drug manufacturing capabilities and play a key role in securing the domestic drug supply. Pramantha has a proven track record and a commitment to excellence that makes it an ideal partner for Lucy as we look to grow our operations."
LSDI has multiple potential catalysts favoring a future of increased growth.
The chart appears to be in bounce mode and is flashing oversold with an RSI of 35.34
https://preview.redd.it/95xu8ndmohpa1.png?width=700&format=png&auto=webp&s=2d6132901007974b02482221cc16248bea43aeeb
A recent report from Data Bridge Market Research said that the psychedelic drugs market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing with a CAGR of 16.3% in the forecast period of 2020 to 2027 and expected to reach USD $6,859.95 million by 2027 from USD 2,077.90 million in 2019. Growing acceptance of psychedelic drugs for treating depression and increasing prevalence of depression and mental disorders are the factors for the market growth. Another report from Research And Markets upped the projection saying that the Psychedelic Drugs Market size is projected to reach USD $10.75 Billion by 2027, from USD 4.75 Bn in 2020 growing at a CAGR of 12.36% during 2021-2027.
It is important to note that approximately 70% of the psychedelics market is attributable to psychedelics manufacturers.
To help with your due diligence, here is a comprehensive report on the psychedelics market from Morgan Stanley.
Disclaimer
submitted by SituationLive4406 to BroadStreetBets [link] [comments]


2023.03.23 13:39 simple-cranberry- It Keeps Getting Worse

I posted on here a few days ago. https://www.reddit.com/BreakUps/comments/11x3oph/im_destroyed/
I broke up with my boyfriend of nearly 4 years on Sunday. I went through his phone and found pictures of girls we went to school with, videos of fully nude girls, and i found a photo compilation of 1 girl (not nude, cleavage and butt pics in tight shorts) who looked very young. Her tik tok handle was in the picture. He posted these on a burner reddit account. I assume he screenshotted stuff off of her tik tok. I couldn’t get over the fact she looked no older than 15. (He is 23.) I went to her tik tok and discovered she is 13 and in 7th grade. I got physically sick when I discovered this. It is like he was living a double life our whole relationship and now i’m questioning if I was dating a pedophile for almost 4 years. I have felt sick for 2 days straight. I don’t know what to do or say. I am so disturbed. I want this to just be a bad nightmare. I’m kind of just using this space to vent in hopes people will somewhat understand. I don’t know what to do anymore.
submitted by simple-cranberry- to BreakUps [link] [comments]


2023.03.23 10:55 learnexams2023 When assignments start getting tough, take a break and learnexams will find study materials for you

100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Longitudinal Waves GIZMO ( ALL ANSWERS CORRECT )-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Longitudinal Waves Prior Knowledge Questions ​(Do these BEFORE using the Gizmo.) In many science fiction movies, an evil alien spaceship explodes with an enormous KABOOM!! S...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Cheryshev-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMO Limiting Reactants SE(ALL ANSWERS CORRECT)-GRADED A+-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Limiting Reactants Vocabulary: chemical equation, chemical formula, chemical reaction, coefficient, limiting reactant, molecule, product, reactant, subscript Prior Knowledge Qu...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By d.occ-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMOs - Observing Weather - Answer Key 100% Correct-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMOs - Observing Weather - Answer Key-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Academia1434-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMOs - H-R Diagram - Complete Answer Key-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMOs - H-R Diagram - Complete Answer Key Vocabulary: giant, H-R diagram, luminosity, main sequence, star, supergiant, white dwarf-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Academia1434-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMO Stoichiometry Answers < all answers correct >-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Stoichiometry Directions: Follow the instructions to go through the simulation. Respond to the questions and prompts in the orange boxes. Vocabulary: Avogadro’s number, balance...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Cheryshev-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMO CORAL REEFS 1-ABIOTIC FACTORS -ALL ANSWERS CORRECT-GRADED A-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Coral Reefs 1 – Abiotic Factors Vocabulary: consumer, coral, coral bleaching, coral reef, filter feeder, food chain, food web, grazer, nutrients, ocean acidification, pH, plankt...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By d.occ-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Gizmos, DNA Profiling - Answer Key [TOP RATED] Instant Download.-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Gizmos Student Exploration: DNA Profiling - Answer Key Vocabulary: DNA polymerase, DNA profiling, gel electrophoresis, gene, mutation, non-coding region, polymerase chain reaction, primer, short tande...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By jakesuli-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Earthquakes 1 – Recording Station GIZMO < ALL ANSWERS CORRECT>-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Earthquakes 1 – Recording Station Vocabulary: body wave, earthquake, epicenter, fault, focus, P-wave, S-wave, seismic wave, seismogram, seismograph Prior Knowledge Questions (D...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Cheryshev-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Coral Reefs 1 Gizmo - Abiotic Factors -ALL ANSWERS CORRECT-GRADED A-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Coral Reefs 1 – Abiotic Factors Vocabulary: consumer, coral, coral bleaching, coral reef, filter feeder, food chain, food web, grazer, nutrients, ocean acidification, pH, plan...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By d.occ-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMO SOLSAR SYSTEM EXPLOLER ANSWERS-REVIEWED AND GRADED BY EXPERTS-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Solar System Explorer Answer Key Vocabulary: astronomical unit, dwarf planet, eccentricity, ellipse, gas giant, Kepler’s laws, orbit, orbital radius, period, planet, solar system, terrestrial planet...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By d.occ-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Gizmos - Orbital Motion – Kepler’s Laws Answer Key 2022-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Gizmos - Orbital Motion – Kepler’s Laws Answer Key Vocabulary: astronomical unit, eccentricity, ellipse, force, gravity, Kepler’s first law, Kepler’s second law, Kepler’s third law, orbit, orbital rad...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Academia1434-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMOs - Convection Cells - Answer key-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
convection, convection cell, density, global conveyor belt, mantle, mid-ocean ridge, subduction zone, vector, viscosity-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Academia1434-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
herscel_experiment_riley GIZMO ( ALL ANSWERS CORRECT )-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Herschel Experiment Vocabulary: electromagnetic radiation, infrared radiation, prism, ultraviolet radiation, visible spectrum Prior Knowledge Questions (Do these BEFORE using t...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Cheryshev-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMO Nuclear Reactions-ALL ANSWERS CORRECT-GRADED A.-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Nuclear Reactions [Note to teachers and students: This Gizmo was designed as a follow-up to the Nuclear Decay Gizmo. We recommend doing that activity before trying this one.] V...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By d.occ-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMO Comparing Climates (Metric) SE ALL ANSWERS CORRECT-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Comparing Climates (Metric) [Note to teachers and students: This lesson was designed as a follow-up to the Observing Weather (Metric) lesson. We recommend doing that activity be...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By d.occ-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Questions and Answers > GIZMOS: Student Exploration: Hardy-Weinberg Equilibrium-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Name: Steven Maldonado Date: May 2, 2017 Student Exploration: Hardy-Weinberg Equilibrium Vocabulary: allele, genotype, Hardy-Weinberg equation, Hardy-Weinberg principle, heterozygous, homozy...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Kirsch-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMO - Lab 22: Student Exploration Reaction Energy Answers(RATED BEST)-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMO - Lab 22: Student Exploration Reaction Energy Answers(RATED BEST)-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Hannington-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Gizmo_Student Exploration: Estimating Population Size 2021 ALL ANSWERS CORRECT GRADED A+-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Directions: Follow the instructions to go through the simulation. Respond to the questions and prompts in the orange boxes. Vocabulary: percent error, population, sample Prior Knowledge Questions (...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By d.occ-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Hurricane Motion Answer Key GIZMO-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Hurricane Motion Answer Key Vocabulary: air pressure, Coriolis effect, eye, hurricane, knot, meteorologist, precipitation Prior Knowledge Questions (Do these BEFORE using the Gizmo.) [Note: The pur...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Cheryshev-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Cell Types Gizmos.pdf. Gizmos, questions and answers. 100% proven pass rate,. Graded A+-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Vocabulary: ATP, bacteria, carbon dioxide (CO2 ), cell, cellular respiration, compound light microscope, eukaryote, multicellular, muscle cell, neuron, organelle, photosynthesis, prokaryote, protist...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By A grade master-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
River Erosion GIZMO-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: River Erosion Vocabulary: cutbank, discharge, erosion, flood, floodplain, meander, meandering river, oxbow lake, point bar, river speed, sediments, slope, streambank, streambed, t...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Tutor Frankline-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Gizmos - Free-Fall Laboratory - Answer Key, Complete Solution.-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Free-Fall Laboratory Answer Key Vocabulary: acceleration, air resistance, free fall, instantaneous velocity, terminal velocity, velocity, vacuum Prior Knowledge Questions (Do these BEFORE using the...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Academia1434-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMOS. Student Exploration: Waves. MATH 101 Waves.-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Waves Vocabulary: amplitude, compression, crest, frequency, longitudinal wave, medium, period, power, rarefaction, transverse wave, trough, wave, wavelength, wave speed Prior K...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Kirsch-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMOS_ Student Exploration BIOLOGY MISCFastPlants1-Growth and Genetics.-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
2019 Name: Date: Student Exploration: Fast Plants® 1 – Growth and Genetics Note to teachers and students: The Fast Plants® Gizmo was created in collaboration with the Wisconsin Fast Plants Program...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By QuizMaster-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMOs : Archimedes’ Principle - Answer Key [TOP RATED]-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMOs : Archimedes’ Principle - Answer Key [TOP RATED] Vocabulary: Archimedes’ principle, buoyant force, density, displace, mass, volume, weight-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Academia1434-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Gizmo Crumple Zones 2021 -ALL ANSWERS CORRECT-GRADED A-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Crumple Zones Vocabulary: acceleration, airbag, collision avoidance system, crash test dummy, crumple zone, force, kinetic energy, Newton’s laws of motion, safety cell, seat bel...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By d.occ-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Half-life Gizmo KEY-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Half-life Answer Key Vocabulary: daughter atom, decay, Geiger counter, half-life, isotope, neutron, radiation, radioactive, radiometric dating Prior Knowledge Questions (Do these BEFORE using the G...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Cheryshev-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Solubility and Temperature Answer Key GIZMO-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Solubility and Temperature Answer Key Vocabulary: concentration, dissolve, homogeneous mixture, solubility, solubility curve, solute, solution, solvent Prior Knowledge Questions (Do these BEFORE us...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Cheryshev-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
PHY 111: Feel the Heat SE _ Key GIZMO (QUESTIONS AND ANSWERS) GRADED 100% CORRECT ANSWERS-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Feel the Heat Answer Key Vocabulary: calorimeter, conductor, controlled experiment, dissolve, endothermic, exothermic, insulator, solute, solution, solvent, surroundings, system Prior Knowledge Que...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Book Worm, Certified-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Coastal Winds Gizmo-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Coastal Winds and Clouds Vocabulary​:​ condensation, convection, convection current, land breeze, sea breeze Prior Knowledge Questions ​(Do these BEFORE using the Gizmo​.) A ho...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Muchiri-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Biochemistry>Explore Learning: GIZMO Student Exploration: Meiosis 100% Score-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Vocabulary: anaphase, chromosome, crossover, cytokinesis, diploid, DNA, dominant, gamete, genotype, germ cell, haploid, homologous chromosomes, interphase, meiosis, metaphase, mitosis, ovum, phenoty p...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Prof.Pierro-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Disease Spread Question and Answers-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Prior Knowledge Questions (Do these BEFORE using the Gizmo.) 1. Why do you think it is important to cover your mouth when you cough? __It is important to cover your mouth because if you do not cover...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Nutmegs-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Orbital Motion - Keplers Laws (Gizmo) -correced-GRADED A-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Orbital Motion – Kepler’s Laws Directions: Follow the instructions to go through the simulation. Respond to the questions and prompts in the orange boxes. Vocabulary​:​ astrono...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By d.occ-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
_M2L2_ Gizmo Lab #2_ Earthquake Determination of Epicenter - Honors-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
M2L2: Earthquake 2 – Determination of Epicenter - Honors Name: Mia Anguiano Date: [NOTE TO STUDENTS: This exercise assumes that you have a data table and graph made while using the Earthquakes 1 –...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Cheryshev-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMO: Student Exploration: Calorimetry Lab - Answer key-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Calorimetry Lab Vocabulary: calorie, calorimeter, joule, specific heat capacity Prior Knowledge Questions (Do these BEFORE using the Gizmo.) 1. The Latin word calor means “heat...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Academia1434-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMOs - DNA Profiling ,Complete Answer key-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Gizmos : DNA Profiling Vocabulary: DNA polymerase, DNA profiling, gel electrophoresis, gene, mutation, non-coding region, polymerase chain reaction, primer, short tandem repeat Gizmo Warm-up DNA p...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Academia1434-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMO_Student Exploration: Student Exploration: Density Laboratory-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Density Laboratory Directions: Follow the instructions to go through the simulation. Respond to the questions and prompts in the orange boxes. Vocabulary​:​ buoyancy, density,...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By QuizMaster-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMO Coral Reefs 2-Biotic Factors -ALL ANSWERS CORRECT -GRADED A+-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Coral Reefs 2 – Biotic Factors [This lesson was designed as a follow-up to the Coral Reefs 1 – Abiotic Factors lesson. Students should complete that activity before trying this...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By d.occ-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Gizmo Radiation Answer Key-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Vocabulary: filament, infrared, Kelvin scale, radiation Prior Knowledge Questions (Do these BEFORE using the Gizmo.) [Note: The purpose of these questions is to activate prior knowledge and get...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Pravil-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Roller Coaster Physics-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Vocabulary (refer to vocab file located on the Gizmo site for definitions): friction, gravitational potential energy, kinetic energy, momentum Prior Knowledge Questions (Do these BEFORE using the G...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Tutor Frankline-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Measuring Volume-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Measuring Volume Vocabulary: cubic centimeter, diameter, graduated cylinder, meniscus, milliliter, pipette, radius, rectangular prism, sphere, volume, water displacement Prior...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By A grade master-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Copy of Limiting Reactants-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Prior Knowledge Questions ​(Do these BEFORE using the Gizmo​.) Imagine you and your friends are making hot dogs. A complete hot dog consists of a wiener and a bun. At the store, you buy four package...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By QuizGuider82-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Electrons and Chemical Reactions STEM Case Gizmos-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Unit 4 Lab Part A Electrons and Chemical Reactions STEM Case Gizmos 57 pts Please use your user name and password to login to explorelearning.com. Then look for the Electrons and Chemical Reactions...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Cheryshev-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMOs - Collision Theory: Answer key 2022 (100% VERIFIED)-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Collision Theory Vocabulary: activated complex, catalyst, chemical reaction, concentration, enzyme, half-life, molecule, product, reactant, surface area-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Academia1434-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Gizmos - Erosion Rates; Answer Key - 2022 Guaranteed A+ (100% Correct)-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Gizmos - Erosion Rates; Answer Key - 2022 Guaranteed A+ (100% Correct) Vocabulary: climate, erosion, precipitation, sandstone, shale, vegetation, valley, weathering Gizmos - Erosion Rates; Answer Ke...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By jakesuli-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
2D Collisions GIZMO ( VERIFIED ANSWERS, 100% CORRECT ) DOWNLOAD TO SCORE A+ GUARANTEED GRADES-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: 2D Collisions Directions: Follow the instructions to go through the simulation. Respond to the questions and prompts in the orange boxes. Vocabulary​:​ center of mass, conserva...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Cheryshev-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMO CORAL REEFS 2- BIOTIC FACTORS ALL ANSWERS CORRECT- GRADED A+ UPDATED 2021-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMO CORAL REEFS 2- BIOTIC FACTORS ALL ANSWERS CORRECT- GRADED A+ UPDATED 2021-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By d.occ-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Gizmo - Rock Classification - Answer Key - 2020-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Vocabulary: classify, extrusive igneous rock, foliation, fossil, igneous rock, intrusive igneous rock, metamorphic rock, mineral, sedimentary rock, strata, texture-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Academia1434-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Simple Harmonic Motion Gizmo 2021-Graded A+-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Simple Harmonic Motion Vocabulary: controlled experiment, harmonic motion, oscillation, pendulum, period, spring, spring constant Prior Knowledge Questions (Do these BEFORE usi...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By d.occ-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
3D Eclipse GIZMO ( ALL ANSWERS 100% CORRECT )-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
ANSWERS IN A CONTRASTING FONT Student Exploration: 3D Eclipse Vocabulary: eclipse, lunar eclipse, path of totality, penumbra, solar eclipse, umbra Prior Knowledge Questions (Do these BEFORE using...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Muchiri-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Gizmos Feel the Heat SE_Answer Key_100% Correct PHY 111 Gizmos Feel the Heat Student Exploration-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Gizmos Feel the Heat SE_Answer Key_100% Correct Feel the Heat Answer Key Vocabulary: calorimeter, conductor, controlled experiment, dissolve, endothermic, exothermic, insulator, solute, solution, s...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Elli-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Measuring volume Gizmo 100% guide-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Vocabulary: cubic centimeter, diameter, graduated cylinder, meniscus, milliliter, pipette, radius, rectangular prism, sphere, volume, water displacement Prior Knowledge Question (Do this BEFORE usin...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Nutmegs-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Collins Hill High School SCIENCE PHYSICS - Electromagnetic Induction Gizmo-VERIFIED BY EXPERTS-GRADED A+-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Electromagnetic Induction Vocabulary​:​ current, electric field, electromagnetic induction, magnetic field, magnetic flux, right-hand rule, vector, voltage, wind generator Prio...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By d.occ-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Gizmos Student Exploration: Hardy-Weinberg Equilibrium Answer Key Top Rated-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Gizmos Student Exploration: Hardy-Weinberg Equilibrium Answer Key Grade A+ Gizmos Student Exploration: Hardy-Weinberg Equilibrium Answer Key Grade A+ Gizmos Student Exploration: Hardy-Weinberg Equil...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By QUIZCzAR-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
PHYSICS 12Week_15_Gizmo_Magnetic_Induction-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Magnetic Induction Vocabulary: current, induced magnetic field, magnetic field, Pythagorean Theorem, right-hand rule Prior Knowledge Questions (Do these BEFORE using the Gizmo....-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Muchiri-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Gizmos Feel The Heat Answer Key-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Feel the Heat Answer Key Vocabulary: calorimeter, conductor, controlled experiment, dissolve, endothermic, exothermic, insulator, solute, solution, solvent, surroundings, system Prior Knowledg...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Quiz Merchant-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMOs - Archimedes Principle (SE) 100% correct answer key-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMOs - Archimedes Principle (SE) 100% correct answer key-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By evekendra-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMOs - Student Exploration: Radiation - Answer Key 2021-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Radiation Answer Key Vocabulary: filament, infrared, Kelvin scale, radiation Prior Knowledge Questions (Do these BEFORE using the Gizmo.) [Note: The purpose of these questions is to activate prior...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Academia1434-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
River Erosion GIZMO 2019-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: River Erosion Vocabulary: cutbank, discharge, erosion, flood, floodplain, meander, meandering river, oxbow lake, point bar, river speed, sediments, slope, streambank, streambe d,...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Tutor Frankline-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Convection Cells student worksheet GIZMO-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Convection Cells Vocabulary: convection, convection cell, density, global conveyor belt, mantle, mid-ocean ridge, subduction zone, vector, viscosity Prior Knowledge Questions (...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Cheryshev-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Gizmos - Student Exploration: Half-life - Questions with true Answers-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Gizmos - Student Exploration: Half-life - Questions with true Answers-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Academia1434-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Gizmos Student Exploration: Weathering-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Vocabulary: abrasion, chemical weathering, clay formation, climate, dissolving, frost wedging, granite, limestone, mechanical weathering, rusting, sandstone, shale, weathering Prior Knowledge Questi...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Tutor Frankline-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Moles GIZMO ( ALL ANSWERS CORRECT )-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Moles Vocabulary: atomic mass, Avogadro constant, conversion factor, dimensional analysis, mole, molar mass, molecular mass, scientific notation, significant figures, unified at...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Cheryshev-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMOs - Coulomb Force (Static) Answer key (TOP RATED)-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMOs - Coulomb Force (Static) Answer key (TOP RATED)-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Academia1434-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Coral Reefs 2 – Biotic Factors-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Coral Reefs 2 – Biotic Factors Prior Knowledge Questions (Do these BEFORE using the Gizmo.) In 1992, Hurricane Andrew left a wake of destruction through Florida. One victim of...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Quizmaster001-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Gizmos Student Exploration: Hardy-Weinberg Equilibrium Answer Key Grade A+-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Gizmos Student Exploration: Hardy-Weinberg Equilibrium Answer Key Grade A+-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Quiz Merchant-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Gizmos: Student Exploration: Feed the Monkey (Projectile Motion) 2021 Graded A-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Feed the Monkey (Projectile Motion) Vocabulary: acceleration, free fall, trajectory, vector, velocity Prior Knowledge Questions (Do these BEFORE using the Gizmo.) Eccentric bil...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Academia1434-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMO SENSES -ALL ANSWERS CORRECT -GRADED A-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Senses Directions: Follow the instructions to go through the simulation. Respond to the questions and prompts in the orange boxes. Vocabulary​:​ auditory cortex, auditory nerve...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By d.occ-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Star Spectra GIZMO-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Star Spectra Directions: Follow the instructions to go through the simulation. Respond to the questions and prompts in the orange boxes. Vocabulary: absorption spectrum, binary...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Cheryshev-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMO LEARNING: American College of International Academics, Lahore - Student Exploration: Chicken Genetics SE. allele, codominant, dominant, genotype, heterozygous, homozygous, phenotype, probability, Punnett square, recessive, trialAll Questions Answered.-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Chicken Genetics Vocabulary​:​ allele, codominant, dominant, genotype, heterozygous, homozygous, phenotype, probability, Punnett square, recessive, trial Prior Knowledge Questi...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By QuizMaster-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
GIZMOs Lab Results for Reaction Energy - Answers (100% score)-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Lab 22: Reaction Energy Directions: Follow the instructions to go through the simulation. Respond to the questions and prompts in the orange boxes. Vocabulary: calorimeter, chemical bond, endothermic,...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Academia1434-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Gizmos - Student Exploration: Refraction FULL Answer key.-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Refraction Vocabulary: angle of incidence, angle of refraction, frequency, index of refraction, medium, refraction, Snell’s law, total internal reflection, wave front, wavelengt...-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
By Academia1434-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
Student Exploration: Earthquakes 1 – Recording Station GIZMO-100% COMPLETE SOLUTIONS DOWNLOAD TO SCORE OUTSTANDING GRADE A
submitted by learnexams2023 to u/learnexams2023 [link] [comments]